Advertisement

Chronic renal failure

  • V. E. Andreucci

Abstract

Nephrologists may be very proud to have developed excellent techniques for replacing renal function and to have improved renal graft survival to such an extent that the kidney is the only organ for which transplantation is now a routine. Unfortunately, the same cannot be said concerning the conservative management of chronic renal failure (CRF), defined as the use of therapeutic measures other than dialysis or transplantation. When renal function is impaired because of chronic renal disease, GFR slowly and progressively declines, leading inexorably to dialysis or death. Undoubtedly chronic uraemia per se contributes to this progression through such factors as the intrarenal deposition of either uric acid, secondary to hyperuricaemia, or calcium salts, secondary to high plasma calcium x phosphorus product, and the renal damage induced by urinary tract infections which are so frequently asymptomatic, or by hypertension, which may itself be caused by CRF. Even though the correction of hypertension, the adequate treatment of urinary infections and well-balanced dietary measures cannot avoid the evolution of chronic uraemia, they may slow its progression1–3.

Keywords

Chronic Renal Failure Metabolic Acidosis Secondary Hyperparathyroidism Chronic Renal Disease Renal Osteodystrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kluthe, R., Oeschlen, D., Quirin, H. and Jedinsky, H. J. (1971). Six years experience with a special low-protein diet. In Kluthe, R., Berlyne, G. and Burton, B. (eds.) Uremia: International Conference on Pathogenesis, Diagnosis and Therapy, p. 250. (Stuttgart: Georg Thieme Verlag)Google Scholar
  2. 2.
    Johnson, W. J., O’Kane, H., Woods, J. E. and Elveback, L. R. (1973). Survival of patients with end-stage renal disease. Mayo Clin. Proc. 48, 18PubMedGoogle Scholar
  3. 3.
    Alfrey, A. C. (1976). Chronic renal failure: manifestations and pathogenesis. In Schrier, R. W. (ed.) Renal and Electrolyte Disorders, pp. 319–347. (Boston: Little, Brown and Company)Google Scholar
  4. 4.
    Brunner, F. P., Brynger, H., Chantier, C., Donckerwolcke, R. A., Hathway, R. A., Jacobs, C., Selwood, N. H. and Wing, A. J. (1979). Combined report on regular dialysis and transplantation in Europe, IX, 1978. Proc. Eur. Dial. Transplant. Assoc., 16, 1Google Scholar
  5. 5.
    Andreucci, V. E. (1977). Le Glomerulonefriti, p. 275. (Naples, Italy: Idelson Publisher)Google Scholar
  6. 6.
    Walker, W. G. and Solez, K. (1979). Renal involvement in disorders of connective tissue. In Earley, L. E. and Gottschalk, C. W. (eds.) Strauss and Welt’s Diseases of the Kidney. 3rd Edn., pp. 1259–1288. (Boston: Little, Brown and Company)Google Scholar
  7. 7.
    Fine, L. G., Schlondorff, D., Trizna, W., Gilbert, R. M. and Bricker, N. S. (1978). Functional profile of the isolated uremic nephron. J. Clin. Invest., 61, 1519CrossRefPubMedGoogle Scholar
  8. 8.
    Platt, R. (1952). Structural and functional adaptations in renal failure. Br. Med. J., 1, 1313 and 1372CrossRefPubMedGoogle Scholar
  9. 9.
    Dorhout-Mees, E. J. (1959). Role of osmotic diuresis in impairment of concentrating ability in renal disease. Br. Med. J., 1, 1156CrossRefPubMedGoogle Scholar
  10. 10.
    Dorhout-Mees, E. J. (1959). Relation between maximal urine concentration, maximal water reabsorption capacity and mannitol clearance in patients with renal disease. Br. Med.J., 1, 1159CrossRefPubMedGoogle Scholar
  11. 11.
    Gilbert, R. M., Weber, H., Turchin, L., Fine, L. G., Bourgoignie, J. J. and Bricker, N. S. (1976). A study of the intrarenal recycling of urea in the rat with chronic experimental pyelonephritis. J. Clin. Invest., 58, 1348CrossRefPubMedGoogle Scholar
  12. 12.
    Kokko, J. P. and Rector, F. C. Jr. (1972). Countercurrent multiplication system without active transport in inner medulla. Kidney Int., 2, 214CrossRefPubMedGoogle Scholar
  13. 13.
    Brickner, N. S., Klahr, S. and Lubowitz, H. (1972). The kidney in chronic renal disease. In Maxwell, M. H. and Kleeman, C. R. (eds.) Clinical Disorders of Fluid and Electrolyte Metabolism. 2nd Edn., pp. 697–725. (New York: McGraw-Hill)Google Scholar
  14. 14.
    Bricker, N. S., Bourgoignie, J. J. and Weber, H. (1976). The renal response to progressive nephron loss. In Brenner, B. M. and Rector, F. C. Jr. (eds.) The Kidney, pp. 703–736. (Philadelphia: W. B. Saunders Company)Google Scholar
  15. 15.
    Epstein, F. H. (1977). Disturbances in renal concentrating ability. In Andreoli, T. E., Grantham, J. J. and Rector, F. C. Jr. (eds.) Disturbances in Body Fluid Osmolality, pp. 251–265. (Bethesda: American Physiological Society)Google Scholar
  16. 16.
    Kleeman, C. R., Adams, D. A. and Maxwell, M. H. (1961). An evaluation of maximal water diuresis in chronic renal disease. I. Normal solute intake. J. Lab. Clin. Med., 58, 169PubMedGoogle Scholar
  17. 17.
    Andreucci, V. E. (1978). Manual of Renal Micropuncture, p. 514. (Naples, Italy: Idelson Publisher)Google Scholar
  18. 18.
    Bricker, N. S., Fine, L. G., Kaplan, M., Epstein, M., Bourgoignie, J. J. and Light, A. (1978). ‘Magnification phenomenon’ in chronic renal disease. N. Engl. J. Med., 299, 1287CrossRefPubMedGoogle Scholar
  19. 19.
    Slatopolsky, E., Elkan, I., Weerts, C. and Bricker, N. S. (1968). Studies on the characteristics of the control system governing sodium excretion in uremic man. J. Clin. Invest., 47, 521CrossRefPubMedGoogle Scholar
  20. 20.
    Coleman, A. J., Arias, M., Carter, N. W., Rector, F. C. Jr. and Seldin, D. W. (1966). The mechanism of salt wastage in chronic renal disease. J. Clin. Invest., 45, 1116CrossRefPubMedGoogle Scholar
  21. 21.
    Dal Canton, A., Russo, D., Gallo, R. and Andreucci, V. E. (1981). Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease. Br. Med. J., 282, 595CrossRefGoogle Scholar
  22. 22.
    de Wardener, H. E. (1973). The Kidney. An Outline of Normal and Abnormal Structure and Function, p. 432. (Edinburgh: Churchill Livingstone)Google Scholar
  23. 23.
    Morgan, D. B. and Thomas, T. H. (1979). Water balance and hyponatraemia. Clin. Sci., 56, 517PubMedGoogle Scholar
  24. 24.
    Sherwood, L. M., Mayer, G. P., Ramberg, C. F., Kronberg, D. S., Aurbach, G. D. and Potts, J. T. (1968). Regulation of parathyroid hormone secretion; proportional control by calcium. Lack of effect of phosphate. Endocrinology, 83, 1043CrossRefPubMedGoogle Scholar
  25. 25.
    Reiss, E., Canterbury, J. M., Bercovitz, M. A. and Kaplan, E. L. (1970). The role of phosphate in the secretion of parathyroid hormone in man. J. Clin. Invest., 49, 2146CrossRefPubMedGoogle Scholar
  26. 26.
    Bricker, N. S., Slatopolsky, E., Reiss, E. and Avioli, L. V. (1969). Calcium, phosphorus and bone in renal disease and transplantation. Arch. Intern. Med., 123, 543CrossRefPubMedGoogle Scholar
  27. 27.
    Slatopolsky, E., Caglar, S., Pennell, J. P., Taggart, D. D., Canterbury, J. M., Reiss, E. and Bricker, N. S. (1971). On the pathogenesis of hyperparathyroidism in chronic renal disease. J. Clin. Invest., 50, 492CrossRefPubMedGoogle Scholar
  28. 28.
    Slatopolsky, E., Caglar, S., Gradowska, L., Canterbury, J., Reiss, E. and Bricker, N. S. (1972). On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using ‘proportional reduction’ of dietary phosphorus intake. Kidney Int., 2, 147CrossRefPubMedGoogle Scholar
  29. 29.
    Slatopolsky, E. and Bricker, N. S. (1973). The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int., 2, 141CrossRefGoogle Scholar
  30. 30.
    Avioli, L. V., Birge, S., Lee, S. W. and Slatopolsky, E. (1968). The metabolic fate of vitamin D3– 3H in chronic renal failure. J. Clin. Invest., 47, 2239CrossRefPubMedGoogle Scholar
  31. 31.
    Avioli, L. V., Scott, S., Lee, S. W. and De Luca, H. F. (1969). The nature of the defect in intestinal Ca absorption in chronic renal disease. Science, 166, 1159CrossRefGoogle Scholar
  32. 32.
    Coburn, J. W., Koppel, M. H., Brickman, A. S. and Massry, S. G. (1973). Study of intestinal absorption of calcium in patients with renal failure. Kidney Int., 3, 264CrossRefPubMedGoogle Scholar
  33. 33.
    Slatopolsky, F., Hruska, K. and Rutherford, W. E. (1975). Current concepts of parathyroid hormone and vitamin D metabolism: perturbations in chronic renal disease. Kidney Int., 7, S-90Google Scholar
  34. 34.
    Reiss, E., Canterbury, J. M. and Kanter, A. (1969). Circulating parathyroid hormone concentration in chronic renal insufficiency. Arch. Intern. Med., 124, 417CrossRefPubMedGoogle Scholar
  35. 35.
    Arnaud, C. D. (1973). Hyperparathyroidism and renal failure. Kidney Int., 4, 89CrossRefPubMedGoogle Scholar
  36. 36.
    Arnaud, C. D., Goldsmith, R. S., Bordier, P. J. and Sizemore, G. W. (1974). Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man. Am. J. Med., 56, 785CrossRefPubMedGoogle Scholar
  37. 37.
    Reiss, E. and Canterbury, J. M. (1974). Spectrum of hyperparathyroidism. Am. J. Med., 56, 794CrossRefPubMedGoogle Scholar
  38. 38.
    Kaplan, M. A., Canterbury, J. M., Bourgoignie, J. J., Veliz, G., Gavellas, G., Reiss, E. and Bricker, N. S. (1979). Reversal of hyperparathyroidism in response to dietary phosphorus restriction in the uremic dog. Kidney Int., 15, 43CrossRefPubMedGoogle Scholar
  39. 39.
    Rutherford, W. E., Bordier, P., Marie, P., Hruska, K., Harter, H., Greenwalt, A., Blondin, J., Haddad, J., Bricker, N. and Slatopolsky, E. (1977). Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. J. Clin. Invest., 60, 332CrossRefPubMedGoogle Scholar
  40. 40.
    Goldman, R. and Bassett, S. (1954). Phosphorus excretion in renal failure. J. Clin. Invest., 33, 1623CrossRefPubMedGoogle Scholar
  41. 41.
    Slatopolsky, E., Robson, A. M., Elkan, I. and Bricker, N. S. (1968). Control of phosphate excretion in uremic man. J. Clin. Invest., 47, 1865CrossRefPubMedGoogle Scholar
  42. 42.
    Massry, S. G., Friedler, R. M. and Coburn, J. W. (1973). Excretion of phosphate and calcium. Physiology of their renal handling and relation to clinical medicine. Arch. Intern. Med., 131, 828CrossRefPubMedGoogle Scholar
  43. 43.
    Popovtzer, M. M., Schainuck, L. I., Massry, S. G. and Kleeman, C. R. (1970). Divalent ion excretion in chronic kidney disease. Relation to degree of renal insufficiency. Clin. Sci., 38, 297PubMedGoogle Scholar
  44. 44.
    Stanbury, S. W. (1971). Calcium and phosphorus metabolism in renal failure. In Strauss, M. B. and Welt, L. G. (eds.) Diseases of the Kidney. 2nd Edn., pp. 305–333. (Boston: Little, Brown and Company)Google Scholar
  45. 45.
    Brickman, A. S., Coburn, J. W., Rowe, P. H., Massry, S. G. and Norman, A. W. (1974). Impaired calcium absorption in uremic man: evidence for defective absorption in the proximal small intestine. J. Lab. Clin. Med., 84, 791Google Scholar
  46. 46.
    Parker, R. F., Vergne-Marini, P., Hull, A. R., Pak, C. Y. C. and Fortran, J. S. (1974). Jejunal absorption and secretion of calcium in patients with chronic renal disease on hemodialysis. J. Clin. Invest., 54, 358CrossRefPubMedGoogle Scholar
  47. 47.
    Clarkson, E. M., McDonald, S. J. and de Wardener, H. E. (1966). The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure. Clin. Sci., 30, 425PubMedGoogle Scholar
  48. 48.
    Clarkson, E. M., Eastwood, J. B., Koutsaimanis, K. G. and de Wardener, H. E. (1973). Net intestinal absorption of calcium in patients with chronic renal failure. Kidney Int., 3, 258CrossRefPubMedGoogle Scholar
  49. 49.
    Avioli, L. V. (1972). Intestinal absorption of calcium. Arch. Intern. Med., 129, 345CrossRefPubMedGoogle Scholar
  50. 50.
    Avioli, L. V. (1978). Renal osteodystrophy and vitamin D. Dial. Transplant., 7, 244Google Scholar
  51. 51.
    Avioli, L. V. (1978). Controversies regarding uremia and acquired defects in vitamin D3 metabolism. Kidney Int., 13 (suppl. 8), S-36Google Scholar
  52. 52.
    Counts, S. J., Baylink, D. J., Shen, F. H., Scherrard, D. J. and Hickman, R. O. (1975). Vitamin D intoxication in an anephric child. Ann. Intern. Med., 82, 196PubMedGoogle Scholar
  53. 53.
    Stern, P., De Luca, H. F. and Ikekawa, N. (1975). Bone-resorbing activities of 24-hydroxy stereoisomers of 24-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Bio-chem. Biophys. Res. Commun., 67, 965CrossRefGoogle Scholar
  54. 54.
    Atkins, D. (1976). A possible role of 24,25-dihydroxycholecalciferol in bone resorption. J. Endocrinol, 69, 28PGoogle Scholar
  55. 55.
    Lee, S. W., Russell, J. and Avioli, L. V. (1977). 25-Hydroxycholecalciferol to 1,25-dihydroxycholecalciferol: conversion impaired by systemic metabolic acidosis. Science, 195, 994CrossRefPubMedGoogle Scholar
  56. 56.
    Gray, R. W., Wilz, D. R., Calda, A. E. and Lemann, J. Jr. (1977). The importance of phosphate in regulating plasma l,25(OH)2 vitamin D levels in humans: studies in healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab., 45, 299CrossRefPubMedGoogle Scholar
  57. 57.
    Lumb, G. A., Mawer, E. B. and Stanbury, S. W. (1971). The apparent vitamin D resistance of chronic renal failure. Am. J. Med., 50, 421CrossRefGoogle Scholar
  58. 58.
    Brancaccio, D., Graziani, G., Galmozzi, C. and Ponticelli, C. (1977). 25-Hydroxyvitamin deficiency and osteomalacia in chronic renal failure. Lancet, 1, 199CrossRefPubMedGoogle Scholar
  59. 59.
    Kanis, J. A., Oliver, D., Ledingham, J. G. G. and Russell, R. G. G. (1976). Evidence that endogenous calcitonin protects against renal bone disease. Lancet, 2, 1322PubMedGoogle Scholar
  60. 60.
    Martin, B. F. and Jacoby, F. (1949). Diffusion phenomenon complicating the histo-chemical reaction for alkaline phosphatase. J. Anat., 83, 351PubMedGoogle Scholar
  61. 61.
    Tänzer, F. S. and Navia, J. M. (1973). Calcitonin inhibition of intestinal phosphate absorption. Nature (London), 242, 221Google Scholar
  62. 62.
    Avioli, L. V. and Teitelbaum, S. L. (1979). Renal osteodystrophy. In Earley, L. E. and Gottschalk, C. W. (eds.) Strauss and Welt’s Diseases of the Kidney. 3rd Edn., pp. 307–370. (Boston: Little, Brown and Company)Google Scholar
  63. 63.
    Haussler, M. R. and McCain, T. H. (1977). Basic and clinical concepts related to vitamin D metabolism and action. N. Engl. J. Med., 297, 974CrossRefPubMedGoogle Scholar
  64. 64.
    Habener, J. F. and Potts, J. T. (1978). Biosynthesis of parathyroid hormone. N. Engl. J. Med., 299, 635CrossRefPubMedGoogle Scholar
  65. 65.
    Stanbury, S. W. (1966). The treatment of renal osteodystrophy. Ann. Intern. Med., 65, 1133PubMedGoogle Scholar
  66. 66.
    Vosik, W. M., Anderson, C. F., Steffee, W. P., Johnson, W. J., Arnaud, C. D. and Goldsmith, R. S. (1972). Successful medical management of osteitis fibrosa due to ‘tertiary’ hyperparathyroidism. Mayo Clin. Proc., 47, 110PubMedGoogle Scholar
  67. 67.
    Buckle, R. M. (1970). Hyperparathyroidism in chronic renal failure: assessment of autonomy by plasma-parathyroid hormone response to alterations in calcium. Lancet, 2, 234CrossRefPubMedGoogle Scholar
  68. 68.
    O’Riordan, J. L. H., Page, J., Kerr, D. N. S., Walls, J., Moorhead, J., Crockett, R. E., Franz, H. and Ritz, E. (1970). Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. Q. J. Med., 39, 359PubMedGoogle Scholar
  69. 69.
    Eastwood, J. B., Bordier, Ph. J. and de Wardener, H. E. (1973). Some biochemical, histological, radiological and clinical features of renal osteodystrophy. Kidney Int., 4, 128CrossRefPubMedGoogle Scholar
  70. 70.
    Stanbury, S. W. (1968). Bone disease in uremia. Am. J. Med., 44, 714CrossRefPubMedGoogle Scholar
  71. 71.
    Stanbury, S. W., Lumb, G. A. and Mawer, E. B. (1969). Osteodystrophy developing spontaneously in the course of chronic renal failure. Arch. Intern. Med., 124, 274CrossRefPubMedGoogle Scholar
  72. 72.
    Massry, S. G. and Coburn, J. W. (1972). Renal osteodystrophy. In Maxwell, M. H. and Kleeman, C. R. (eds.) Clinical Disorders of Fluid and Electrolyte Metabolism. 2nd Edn., pp. 505–539. (New York: McGraw-Hill)Google Scholar
  73. 73.
    Katz, A. I., Hampers, C. L., Wilson, R. E., Bernstein, D. S., Washman, A. and Merrill, J. P. (1968). The place of subtotal parathyroidectomy in the management of patients with chronic renal failure. Trans. Am. Artif. Intern. Organs, 14, 376Google Scholar
  74. 74.
    Massry, S. G. and Coburn, J. W. (1976). Divalent ion metabolism and renal osteodystrophy. In Massry, S. G. and Sellers, A. (eds.) Clinical Aspects of Uremia and Dialysis. pp. 304–387. (Springfield, Ill.: C. C. Thomas)Google Scholar
  75. 75.
    Katz, A. I., Hampers, C. L. and Merrill, J. P. (1969). Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Medicine, 48, 333CrossRefPubMedGoogle Scholar
  76. 76.
    Haust, M. D., Landing, B. H., Holmstrand, K., Currarino, G. and Smith, B. S. (1964). Osteosclerosis of renal disease in children: comparative pathologic and radiographic studies. Am. J. Pathol., 44, 141PubMedGoogle Scholar
  77. 77.
    Mehls, O., Ritz, E., Krempien, B., Willich, E., Bommer, J. and Schärer, K. (1973). Roentgenological signs in the skeleton of uremic children: an analysis of the anatomical principles underlying the roentgenological changes. Pediatr. Radiol., 1, 183CrossRefPubMedGoogle Scholar
  78. 78.
    Campos, C., Arata, R. O. and Mautalen, C. A. (1976). Parathyroid hormone and vertebral osteosclerosis in uremic patients. Metabolism, 25, 495CrossRefPubMedGoogle Scholar
  79. 79.
    Kaln, D. N., Doyle, F. H., Pennock, J. and Foster, G. V. (1970). Parathyroid hormone and experimental osteosclerosis. Lancet, 1, 1363Google Scholar
  80. 80.
    Jaworski, Z. F. G., Lok, E. and Wellington, J. L. (1975). Impaired osteoclastic function and linear bone erosion rate in secondary hyperparathyroidism associated with chronic renal failure. Clin. Orthop., 107, 298CrossRefPubMedGoogle Scholar
  81. 81.
    Parsons, V., Davies, C., Goode, C., Ogg, C. and Siddiqui, J. (1971). Aluminium in bone from patients with renal failure. Br. Med. J., 4, 73Google Scholar
  82. 82.
    Conger, J. D., Hammond, W. S., Alfrey, A. C., Contiguglia, S. R., Stanford, R. E. and Huffer, W. E. (1975). Pulmonary calcification in chronic dialysis patients. Ann. Intern. Med., 83, 330PubMedGoogle Scholar
  83. 83.
    Oreopoulos, D. G., Pitel, S. and Husdan, H. (1974). Contrasting effect of haemodialysis and peritoneal dialysis on the inhibition of in vivo calcifications by uremic serum. Can. Med. Assoc. J., 110, 43PubMedGoogle Scholar
  84. 84.
    Velentzas, C. and Oreopoulos, D. G. (1979). Soft tissue calcification in chronic renal failure. Int. J. Artif. Organs, 2, 6PubMedGoogle Scholar
  85. 85.
    Berkow, J. W., Fine, B. S. and Zimmerman, L. E. (1964). Unusual ocular calcification in hyperparathyroidism. Am. J. Ophthalmol., 66, 814Google Scholar
  86. 86.
    Berlyne, C. M. and Shaw, A. G. (1967). Red eyes in renal failure. Lancet, 1, 4CrossRefPubMedGoogle Scholar
  87. 87.
    Berlyne, C.M. (1968). Microcrystalline conjunctival calcification in renal failure: a useful clinical sign. Lancet, 2, 366CrossRefPubMedGoogle Scholar
  88. 88.
    Caner, J. E. and Decker, J. L. (1964). Recurrent acute (? gouty) arthritis in chronic renal failure treated with periodic hemodialysis. Am J. Med., 36, 571CrossRefPubMedGoogle Scholar
  89. 89.
    Continguglia, S. R., Alfrey, A. C., Miller, N. L., Runnels, D. E. and Le Geros, R. Z. (1973). Nature of soft tissue calcification in uremia. Kidney Int., 4, 229CrossRefGoogle Scholar
  90. 90.
    Boner, G., Jacob, E. T., Perzner, S. and Jungmann, A. (1971). Diffuse calcification of lungs in a patient on maintenance hemodialysis. Isr. J. Med. Sci., 7, 1182PubMedGoogle Scholar
  91. 91.
    Terman, D. S., Alfrey, A. C., Hammond, W. S., Donndelinger, T., Ogden, D. A. and Holmes, J. H. (1971). Cardiac calcification in uremia. Am. J. Med., 50, 744CrossRefPubMedGoogle Scholar
  92. 92.
    Carlström, D., Engfeldt, B., Engström, A. and Ringertz, N. (1953). Studies on the chemical composition of normal and abnormal blood vessel walls. I. Chemical nature of calcified deposits. Lab. Invest., 2, 325PubMedGoogle Scholar
  93. 93.
    Bernstein, D. S., Pletka, P., Hartner, R. S., Hampers, C. L. and Merrill, J. P. (1971). Effect of total parathyroidectomy and uremia on the chemical composition of bone, skin, and aorta in rats. Isr. J. Med. Sci., 7, 513PubMedGoogle Scholar
  94. 94.
    Arieff, A. I. and Massry, S. G. (1974). Calcium metabolism of brain in acute renal failure. J. Clin. Invest., 53, 387CrossRefPubMedGoogle Scholar
  95. 95.
    Massry, S. G., Popovtzer, M. M., Coburn, J. W., Makoff, D. L., Maxwell, M. H. and Kleeman, C. R. (1968). Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. N. Engl. J. Med., 279, 697CrossRefPubMedGoogle Scholar
  96. 96.
    Massry, S. G., Coburn, J. W., Hartenbower, D. L., Shinaberger, J. H., de Palma, J. R., Chapman, E. and Kleeman, C. R. (1970). Mineral contents of the human skin in uremia: effect of secondary hyperparathyroidism and hemodialysis. Proc. Eur. Dial. Transplant. Assoc., 7, 146Google Scholar
  97. 97.
    Gilchrest, B. (1978). Uremic pruritus. Management and possible pathogenesis. Dial. Transplant., 7, 1021Google Scholar
  98. 98.
    Massry, S. G., Coburn, J. W., Hortenbower, D., Shinaberger, J. H., de Palma, G. R., Chapman, E. and Kleeman, C. R. (1971). The effect of calcemic disorders and uremia on the mineral content of skin. Isr. J. Med. Sci., 7, 514PubMedGoogle Scholar
  99. 99.
    Hampers, C. L., Katz, A. J., Wilson, R. E. and Merrill, J. P. (1968). Disappearance of ‘uremic’ itching after subtotal parathyroidectomy. N. Engl. J. Med., 279, 695CrossRefPubMedGoogle Scholar
  100. 100.
    Walser, M., Mitch, W. E. and Collier, V. U. (1979). The effect of nutritional therapy on the course of chronic renal failure. Clin. Nephrol., 11, 66PubMedGoogle Scholar
  101. 101.
    Legros, R. Z., Contiguglia, S. R. and Alfrey, A. C. (1973). Pathological calcifications associated with uremia. Two types of calcium phosphate deposits. Calc. Tiss. Res., 13, 173CrossRefGoogle Scholar
  102. 102.
    Alfrey, A. C., Solomons, C. C., Cincilla, J. and Miller, N. L. (1976). Extraosseous calcification: evidence for abnormal pyrophosphate metabolism in uremia. J. Clin. Invest., 57, 692CrossRefPubMedGoogle Scholar
  103. 103.
    Whittier, F. and Freeman, R. (1971). Potentiation of metastatic calcification in vitamin-D-treated rats by magnesium. Am. J. Physiol., 220, 209PubMedGoogle Scholar
  104. 104.
    Piatt, R. (1950). Sodium and potassium excretion in chronic renal failure. Clin. Sci., 9, 367Google Scholar
  105. 105.
    van Ypersele de Strihou, C. (1977). Potassium homeostasis in renal failure. Kidney Int., 11, 496Google Scholar
  106. 106.
    Silva, P., Hayslett, J. P. and Epstein, F. H. (1973). The role of Na-K-activated adenosine triphosphatase in potassium adaptation. J. Clin. Invest., 52, 2665CrossRefPubMedGoogle Scholar
  107. 107.
    Schon, D. A., Silva, P. and Hayslett, J. P. (1974). Mechanism of potassium excretion in renal insufficiency. Am. J. Physiol., 227, 1323PubMedGoogle Scholar
  108. 108.
    Schrier, R. W. and Regal, E. M. (1972). Influence of aldosterone on sodium, water and potassium metabolism in chronic renal disease. Kidney Int., 1, 156CrossRefPubMedGoogle Scholar
  109. 109.
    Gerstein, A. R., Kleeman, C. R., Gold, E. M., Franklin, S. S., Maxwell, M. H., Gonick, H. C., Feffer, M. L. and Steninman, T. I. (1968). Aldosterone deficiency in chronic renal failure. Nephron, 5, 90CrossRefPubMedGoogle Scholar
  110. 110.
    Schoeneman, M. (1978). Dietary and pharmacologic treatment of chronic renal failure. In Edelmann, C. M. Jr. (ed.) Pediatric Kidney Disease, pp. 475–487. (Boston: Little, Brown and Company)Google Scholar
  111. 111.
    Hayes, C. P., McLeod, M. E., Robinson, R. R. and Stread, E. A. (1967). An extrarenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans. Assoc. Am. Physicians, 80, 207PubMedGoogle Scholar
  112. 112.
    Berlyne, G. M., van Laethem, L. and Ben Ari, J. (1971). Exchangeable potassium and renal potassium handling in advanced chronic renal failure in man. Nephron, 8, 264CrossRefPubMedGoogle Scholar
  113. 113.
    Scribner, B. H. and Burnell, J. M. (1956). Interpretation of the serum potassium concentration. Metabolism, 5, 468PubMedGoogle Scholar
  114. 114.
    Bilbrey, G. L., Carter, N. W., White, M. G., Schilling, J. F. and Knochel, J. P. (1973). Potassium deficiency in chronic renal failure. Kidney Int., 4, 423CrossRefPubMedGoogle Scholar
  115. 115.
    Patrick, J. (1977). The assessment of body potassium stores. Kidney Int., 11, 476CrossRefPubMedGoogle Scholar
  116. 116.
    Burnell, J. M., Villamil, M. F., Nyeno, B. T. and Scribner, B. H. (1956). Effect in humans of extracellular pH change on relationship between serum potassium concentration and intracellular potassium. J. Clin. Invest., 35, 935CrossRefPubMedGoogle Scholar
  117. 117.
    Dickerman, H. W. and Walker, W. G. (1964). Effect of cationic amino acid infusion on potassium metabolism in vivo. Am. J. Physiol., 206, 403Google Scholar
  118. 118.
    Hertz, P. and Richardson, J. A. (1972). Arginine-induced hyperkalemia in renal failure patients. Arch. Intern. Med., 130, 778CrossRefPubMedGoogle Scholar
  119. 119.
    Goldfarb, S., Cox, M., Singer, I. and Goldberg, M. (1976). Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Ann. Intern. Med., 84, 426PubMedGoogle Scholar
  120. 120.
    Perez, G., Siegel, L. and Schreiner, G. E. (1972). Selective hypoaldosteronism with hyperkalemia. Ann. Intern. Med., 76, 757PubMedGoogle Scholar
  121. 121.
    Schambelan, M., Stockigt, J. R. and Biglieri, E. G. (1972). Isolated hypoaldosteronism in adults: a renin-deficiency syndrome. N. Engl. J. Med., 287, 573CrossRefPubMedGoogle Scholar
  122. 122.
    Weidmann, P., Reinhart, R., Maxwell, M. H., Rowe, P., Coburn, J. W. and Massry, S. G. (1973). Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease. J. Clin. Endocrinol. Metab., 36, 965CrossRefPubMedGoogle Scholar
  123. 123.
    Weidmann, P., Maxwell, M. H., Rowe, P., Winer, R. and Massry, S. G. (1975). Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease. Nephron, 15, 35CrossRefPubMedGoogle Scholar
  124. 124.
    De Leiva, A., Christlieb, A. R., Melby, J. C., Graham, C. A., Day, R. P., Luetscher, J. A. and Zager, P. G. (1976). Big renin and biosynthetic defect of aldosterone in diabetes mellitus. N. Engl. J. Med., 295, 639CrossRefGoogle Scholar
  125. 125.
    Luke, R. G., Allison, M. and Davidson, J. (1969). Hyperkalemia and renal tubular acidosis due to renal amyloidosis. Ann. Intern. Med., 70, 1211PubMedGoogle Scholar
  126. 126.
    Popovtzer, M. M., Katz, F. H., Pinggera, W. F., Robinette, J., Halgrimson, C. G. and Butkus, D. E. (1973). Hyperkalemia in salt-wasting nephropathy. Arch. Intern. Med., 132, 203CrossRefPubMedGoogle Scholar
  127. 127.
    Maxwell, M. H. and Kleeman, C. R. (1972). Clinical Disorders of Fluid and Electrolyte Metabolism. 2nd Edn., p. 1164. (New York: McGraw-Hill)Google Scholar
  128. 128.
    Makoff, D. L. and de Palma, J. R. (1976). Electrolyte and acid-base abnormalities. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis, pp. 284–303. (Springfield, Ill.: C. C. Thomas)Google Scholar
  129. 129.
    Makoff, D. L. (1972). Acid-base metabolism. In Maxwell, M. H. and Kleeman, C. R. (eds.) Clinical Disorders of Fluid and Electrolyte Metabolism. 2nd Edn., pp. 297–346. (New York: McGraw-Hill)Google Scholar
  130. 130.
    Relman, A. S., Lennon, E. J. and Lemann, J. Jr. (1961). Endogenous production of fixed acid and the measurement of the net balance of acid in normal subjects. J. Clin. Invest., 40, 1621CrossRefPubMedGoogle Scholar
  131. 131.
    Albert, M. S. and Winters, R. W. (1966). Acid-base equilibrium of blood in normal infants. Pediatrics, 37, 728PubMedGoogle Scholar
  132. 132.
    Kildeberg, P., Engel, K. and Winters, R. W. (1969). Balance of net acid in growing infants. Acta Paediatr. Scand., 58, 321CrossRefPubMedGoogle Scholar
  133. 133.
    Salcedo, J. R., Jackson, M. L., Coleman, T. N., Rao, D. D. and Chan J. M. (1976). Endogenous net acid production in infants, children and adults. Pediatr. Res., 10, 443Google Scholar
  134. 134.
    Welt, L. G. and Burnett, C. H. (1966). Acidosis and alkalosis. In Harrison, T. R. (ed.) Principles of Internal Medicine. 5th Edn., pp. 321–333. (New York: McGraw-Hill)Google Scholar
  135. 135.
    Swan, R. C. and Pitts, R. F. (1955). Neutralization of infused acid by nephrectomized dogs. J. Clin. Invest., 34, 205CrossRefPubMedGoogle Scholar
  136. 136.
    Singer, R. B., Clark, J. K., Barker, E. S., Crosley, A. P. Jr. and Elkinton, R. (1955). The acute effects in man of rapid intravenous infusion of hypertonic bicarbonate solution. I. Changes in acid-base balance and distribution of the excess buffer base. Medicine, 34, 51CrossRefPubMedGoogle Scholar
  137. 137.
    Rector, F. C., Jr., Carter, N. W. and Seldin, D. W. (1965). The mechanism of bicarbonate reabsorption in the proximal and distal tubule of the kidney. J. Clin. Invest., 44, 278CrossRefPubMedGoogle Scholar
  138. 138.
    McCance, R. A. and von Finck, M. A. (1947). Titratable acidity pH, ammonia and phosphate in urines of very young infants. Arch. Dis. Child., 22, 200CrossRefPubMedGoogle Scholar
  139. 139.
    McCance, R. A. and Widdowson, E. M. (1960). Renal aspects of acid-base control in the newly born. Acta Paediatr. Scand., 49, 409CrossRefGoogle Scholar
  140. 140.
    Wrong, O. and Davies, H. E. F. (1959). The excretion of acid in renal disease. Q.J. Med., 28, 259PubMedGoogle Scholar
  141. 141.
    Madison, L. L. and Seldin, D. W. (1955). Adaptation of ammonia-producing enzymes in the human kidney during chronic acidosis as revealed by the administration of precursor amino acids. Clin. Res. Proc., 3, 136Google Scholar
  142. 142.
    Bricker, N. S., Klahr, S. and Rieselbach, R. E. (1964). The functional adaptation of the diseased kidney. I. Glomerular filtration rate. J. Clin. Invest., 43, 1915CrossRefPubMedGoogle Scholar
  143. 143.
    Dorhout-Mees, E. J., Machado, M., Slatopolsky, E., Klahr, S. and Bricker, N. S. (1966). The functional adaptation of the diseased kidney. III. Ammonium excretion. J. Clin. Invest., 45, 289CrossRefPubMedGoogle Scholar
  144. 144.
    Simpson, D. P. (1971). Control of hydrogen in homeostasis and renal acidosis. Medicine, 50, 503CrossRefPubMedGoogle Scholar
  145. 145.
    Davies, H. E. F. and Wrong, O. (1957). Acidity of urine and excretion of ammonium in renal disease. Lancet, 2, 625CrossRefGoogle Scholar
  146. 146.
    Schwartz, W. B. and Polak, A. (1960). Electrolyte disorders in chronic renal disease. J. Chronic Dis., 11, 319CrossRefPubMedGoogle Scholar
  147. 147.
    Schwartz, W. B., Hall, P. W., Hays, R. M. and Relman, A. S. (1959). On the mechanism of acidosis in chronic renal disease. J. Clin. Invest., 38, 39CrossRefPubMedGoogle Scholar
  148. 148.
    Lubowitz, H., Purkerson, M. L., Rolf, D., Weisser, F. and Bricker, N. S. (1971). The effect of nephron loss on proximal tubular bicarbonate reabsorption in the rat. Am. J. Physiol., 220, 457PubMedGoogle Scholar
  149. 149.
    Espines, C. H. (1975). The influence of salt intake on the metabolic acidosis of chronic renal failure. J. Clin. Invest., 56, 286CrossRefGoogle Scholar
  150. 150.
    Raisz, L. G. (1972). Calcium, phosphate, magnesium and trace elements. In Maxwell, M. H. and Kleeman, C. R. (eds.) Clinical Disorders of Fluid and Electrolite Metabolism. 2nd Edn., pp. 347–399. (New York: McGraw-Hill)Google Scholar
  151. 151.
    Muldowney, F. P., Donohue, J. F., Carroll, D. W., Powell, D. and Freaney, R. (1972). Parathyroid acidosis in uremia. Q. J. Med., 41, 321PubMedGoogle Scholar
  152. 152.
    Coe, F. L. (1974). Magnitude of metabolic acidosis in primary hyperparathyroidism. Arch. Intern. Med., 134, 262CrossRefPubMedGoogle Scholar
  153. 153.
    Arruda, J. A. L., Carrasquillo, T., Cubria, A., Rademacher, D. R. and Kartzman, N. A. (1976). Bicarbonate reabsorption in chronic renal failure. Kidney Int., 9, 481CrossRefGoogle Scholar
  154. 154.
    Goodman, A. D., Lemann, J. Jr., Lennon, E. J. and Reiman, A. S. (1965). Production, excretion and net balance of fixed acid in patients with renal acidosis. J. Clin. Invest., 44, 495CrossRefPubMedGoogle Scholar
  155. 155.
    Lemann, J. Jr., Litzow, J. R. and Lennon, E. J. (1966). The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J. Clin. Invest., 45, 1608CrossRefPubMedGoogle Scholar
  156. 156.
    Litzow, J. R., Lemann, J. Jr. and Lennon, E. J. (1967). The effect of treatment of acidosis on calcium balance in patients with chronic azotemic renal disease. J. Clin. Invest., 46, 280CrossRefPubMedGoogle Scholar
  157. 157.
    Valtin, H. (1979). Renal Dysfunction: Mechanisms Involved in Fluid and Solute Imbalance, p. 499. (Boston: Little, Brown and Company)Google Scholar
  158. 158.
    Astrup, P., Jorgensen, K., Siggaard Anderson, O. and Engel, K. (1960). Acid-base metabolism: new approach. Lancet, 1, 1035CrossRefPubMedGoogle Scholar
  159. 159.
    Brackett, N. C. Jr., Cohen, J. and Schwartz, W. B. (1965). Carbon dioxide titration curve of normal man. N. Engl. J. Med., 272, 6CrossRefPubMedGoogle Scholar
  160. 160.
    West, C. D. and Smith, W. C. (1956). An attempt to elucidate the cause of growth retardation in renal disease. Am J. Dis. Child., 91, 460Google Scholar
  161. 161.
    Cooke, R. E., Boyden, D. G. and Haller, E. (1960). The relationship of acidosis and growth retardation. J. Pediatr., 57, 326CrossRefPubMedGoogle Scholar
  162. 162.
    Pellegrino, E. D. and Biltz, R. M. (1965). The composition of human bone in uremia. Medicine, 44, 397CrossRefPubMedGoogle Scholar
  163. 163.
    Kopple, J. D. (1976). Nitrogen metabolism. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis. 2nd Edn., pp. 241–273. (Springfield, Ill.: C. C. Thomas)Google Scholar
  164. 164.
    Bergstrom, J. and Fürst, P. (1978). Uremic toxins. In Proceedings VII International Congress of Nephrology (Montreal, June 18–23, 1978), pp. 669–675. (Basel: S. Karger)Google Scholar
  165. 165.
    Hewlett, A. W., Gilbert, Q. O. and Wickett, A. D. (1916). The toxic effects of urea on normal individuals. Arch. Intern. Med., 18, 636CrossRefGoogle Scholar
  166. 166.
    Javid, M. (1958). Symposium on surgery of the head and neck: urea—new use of an old agent. Surg. Clin. N. Am., 38, 907PubMedGoogle Scholar
  167. 167.
    Merrill, J. P., Legrain, M. and Hoigne, R. (1953). Observations on the role of urea in uremia. Am. J. Med., 14, 519Google Scholar
  168. 168.
    Memoli, B., Calderaro, V., Terracciano, V., Caputo, A., Santoro, L., Perretti, A., Caruso, G. and Andreucci, V. E. (1980). L’emofiltrazione come alternativa all’emodialisi nel trattamento dell’uremia terminale. Risultati preliminari. La Riforma Medica, 95, 535Google Scholar
  169. 169.
    Johnson, W. J., Hagge, W. W., Wagoner, R. D., Dinapoli, R. P. and Rosevear, J. W. (1972). Effects of urea loading in patients with far-advanced renal failure. Mayo Clin. Proc., 47, 21PubMedGoogle Scholar
  170. 170.
    Johnson, W. J., Hagge, W. W., Wagoner, R. D., Dinapoli, R. P. and Rosevear, J. W. (1975). Toxicity arising from urea. Kidney Int., 7 (Suppl. 3), S-288Google Scholar
  171. 171.
    Walser, M. and Bodenlos, L. J. (1959). Urea metabolism in man. J. Clin. Invest., 38, 1617CrossRefPubMedGoogle Scholar
  172. 172.
    Mitch, W. E., Lietman, P. S. and Walser, M. (1977). Effects of oral neomycin and kanamycin in chronic uremic patients. I. Urea metabolism. Kidney Int., 11, 116CrossRefPubMedGoogle Scholar
  173. 173.
    Walser, M. (1974). Urea metabolism in chronic renal failure. J. Clin. Invest., 53, 1385CrossRefPubMedGoogle Scholar
  174. 174.
    Preuss, H. G., Davis, B. B., Maher, J. F., Bise, B. W. and Schreiner, G. E. (1966). Ammonia metabolism in renal failure. Ann. Intern. Med., 65, 54PubMedGoogle Scholar
  175. 175.
    Sorensen, L. B. (1959). Degradation of uric acid in man. Metabolism, 8, 687PubMedGoogle Scholar
  176. 176.
    Steele, T. H. and Rieselbach, R. E. (1967). The contribution of residual nephrons within the chronically diseased kidney to urate homeostasis in man. Am. J. Med., 43, 876CrossRefPubMedGoogle Scholar
  177. 177.
    Steele, T. H. and Rieselbach, R. E. (1976). The renal handling of urate and other organic anions. In Brenner, B. M. and Rector, F. C. Jr. (eds.) The Kidney, pp. 442–476. (Philadelphia: W. B. Saunders Company)Google Scholar
  178. 178.
    Verger, D., Leroux, R. C., Ganter, P. and Richet, G. (1967). Les tophus gotteux de la médullaire rénale des urémiques chroniques: étude de 17 cas découvert au cours de 62 autopsies. Nephron, 4, 356CrossRefPubMedGoogle Scholar
  179. 179.
    Rieselbach, R. E., Bentzel, C. J., Cotlove, E., Frei, E. and Freireich, E. J. (1964). Uric acid excretion and renal function in the acute hyperuricemia of leukemia: pathogenesis and therapy of uric acid nephropathy. Am. J. Med., 37, 872CrossRefPubMedGoogle Scholar
  180. 180.
    Massry, S. G. (1977). Is parathyroid hormone a uremic toxin? Nephron, 19, 125CrossRefPubMedGoogle Scholar
  181. 181.
    Massry, S. G. and Goldstein, D. A. (1978). Role of parathyroid hormone in uremic toxicity. Kidney Int., 13 (Suppl. 8), 39Google Scholar
  182. 182.
    Massry, S. G. and Goldstein, D. A. (1979). The search for uremic toxin(s) “X”. “X” = PTH. Clin. Nephrol., 11, 181PubMedGoogle Scholar
  183. 183.
    Bailey, G. L., Griffith, H. J. L. and Merrill, J. P. (1972). Avascular necrosis of the femoral head in patients on chronic hemodialysis. Trans. Am. Soc. Artif. Intern. Organs, 48, 401CrossRefGoogle Scholar
  184. 184.
    Chatterjee, S. N., Friedler, R. M., Berne, T. V., Oldham, S. G., Singer, F. R. and Massry, S. G. (1976). Persistent hypercalcemia after successful renal transplantation. Nephron, 17, 1CrossRefPubMedGoogle Scholar
  185. 185.
    Massry, S. G., Gordon, A., Coburn, J. W., Kaplan, L., Franklin, S. G., Maxwell, M. H. and Kleeman, C. R. (1970). Vascular calcification and peripheral necrosis in a renal transplant recipient: reversal of lesions following subtotal parathyroidectomy. Am. J. Med., 49, 416CrossRefPubMedGoogle Scholar
  186. 186.
    Gibstein, R. H., Coburn, J. W., Adams, D. A., Lee, D. B. N., Parsa, K. P., Sellers, A., Suki, W. N. and Massry, S. G. (1976). Calciphylaxis in man: a syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal disease. Arch. Intern. Med., 136, 1273CrossRefGoogle Scholar
  187. 187.
    Eschbach, J. W. (1976). Anemia. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis. 2nd Edn., pp. 146–178. (Springfield, Ill.: C. C. Thomas)Google Scholar
  188. 188.
    Brickman, A. S., Sherrard, D. J., Jowsey, J., Singer, F. R., Baylink, D. J., Maloney, N., Massry, S. G., Norman, A. W. and Coburn, J. W. (1974). Effect of 1,25-dihydroxy-cholecalciferol on skeletal lesions and plasma parathyroid hormone in uremic osteo-distrophy. Arch. Intern. Med., 134, 883CrossRefPubMedGoogle Scholar
  189. 189.
    Better, P. S., Shasha, S. M., Windver, J. and Chaimovitz, C. (1976). Improvement in the anemia of hemodialysis patients following parathyroidectomy. Proc. Am. Soc. Nephrol., 9, 1Google Scholar
  190. 190.
    Cantin, M. (1965). Kidney, parathyroid and lipemia. Lab. Invest., 14, 1691PubMedGoogle Scholar
  191. 191.
    Loew, H., Schultz, H. and Busch, G. (1975). Klinische Aspekte der Impotenz mannlicher Dauerdialysepatienten. Med. Welt., 26, 1651PubMedGoogle Scholar
  192. 192.
    Massry, S. G., Goldstein, D. A., Procci, W. R. and Kletsky, O. A. (1977). Impotence in patients with uremia: a possible role for parathyroid hormone. Nephron, 19, 305CrossRefPubMedGoogle Scholar
  193. 193.
    Alfrey, A. C., Mishell, J. M., Burks, J., Contiguglia, S. R., Rudolph, H., Lewin, E. and Holmes, J. H. (1972). Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans. Am. Soc. Artif. Intern. Organs, 18, 257CrossRefPubMedGoogle Scholar
  194. 194.
    Guisado, R., Arieff, A. I. and Massry, S. G. (1975). Changes in the electroencephalogram in acute uremia. J. Clin. Invest., 55, 738CrossRefPubMedGoogle Scholar
  195. 195.
    Goldstein, D. A. and Massry, S. G. (1978). Effects of parathyroid hormone administration and its withdrawal on brain calcium and electroencephalogram. Miner. Elect. Metab., 1, 84Google Scholar
  196. 196.
    Goldstein, D. A., Chui, L. A. and Massry, S. G. (1978). Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. J. Clin. Invest., 62, 88CrossRefPubMedGoogle Scholar
  197. 197.
    Avram, M. M., Iancu, M., Morrow, P., Feinfeld, D. and Huatuco, A. (1979). Uremic syndrome in man: new evidence for parathormone as a multisystem neurotoxin. Clin. Nephrol, 11, 59PubMedGoogle Scholar
  198. 198.
    Simenoff, M. L., Saukonen, J. J., Burke, J. F., Schaedler, R. W., Vogel, W. H., Boree, K. and Lasker, N. (1978). Importance of aliphatic amines in uremia. Kidney Int., 12 (Suppl. 8), S-16Google Scholar
  199. 199.
    Wathen, R., Smith, M., Keshaviah, P., Conty, C. and Shapiro, F. (1975). Depressed in vitro aggregation of platelets of chronic hemodialysis patients: a role for cyclic AMP. Trans. Am. Soc. Artif. Intern. Organs, 21, 320PubMedGoogle Scholar
  200. 200.
    Babb, A. L., Popovich, R. P. and Christopher, T. G. (1971). The genesis of the square meter-hour hypothesis. Trans. Am. Soc. Artif. Intern. Organs, 17, 81PubMedGoogle Scholar
  201. 201.
    Bergstrom, J., Asaba, H., Furst, P., Gordon, A., Quadracci, L. and Zimmerman, L. (1976). Middle molecules in uremia. In Proceedings VI International Congress of Nephrology (Firenze, June 8–12, 1975), pp. 600–611. (Basel: S. Karger)Google Scholar
  202. 202.
    Bergstrom, J. and Furst, P. (1976). Uremic middle molecules. Clin. Nephrol., 5, 143PubMedGoogle Scholar
  203. 203.
    Migone, L., Dall’Aglio, P. and Buzio, C. (1975). Middle molecules in uremic serum, urine and dialysis fluid. Clin. Nephrol., 3, 82PubMedGoogle Scholar
  204. 204.
    Bergstrom, J., Furst, P., Asaba, H. and Oules, R. (1978). Dialysis and middle molecules. Dial. Transplant., 7, 344Google Scholar
  205. 205.
    Bergstrom, J., Furst, P. and Noree, L. O. (1975). Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. I. Nitrogen balance studies. Clin. Nephrol., 3, 187PubMedGoogle Scholar
  206. 206.
    Bergstrom, J. and Fürst, P. (1978). Uremic toxins. Kidney Int., 13 (Suppl. 8), S-9Google Scholar
  207. 207.
    Bergstrom, J., Fürst, P. and Zimmerman, L. (1979). Uremic middle molecules exist and are biologically active. Clin. Nephrol., 11, 229PubMedGoogle Scholar
  208. 208.
    Perkoff, G. T., Clayton, L. T. and Newton, J. D. (1958). Mechanism of impaired glucose intolerance in uremia. Diabetes, 7, 375PubMedGoogle Scholar
  209. 209.
    Westervelt, F. B. Jr. and Shreiner, G. E. (1962). The carbohydrate intolerance of uremic patients. Ann. Intern. Med., 57, 266PubMedGoogle Scholar
  210. 210.
    Bierman, E. L. (1970). Abnormalities of carbohydrate and lipid metabolism in uremia. Arch. Intern. Med., 126, 790CrossRefPubMedGoogle Scholar
  211. 211.
    Fichman, M. P. (1976). Effect of uremia and dialysis on carbohydrate and lipid metabolism. Dial. Transplant., 5, 12Google Scholar
  212. 212.
    Rabbin, R., Simon, N. M. and Steiner, S. (1970). Effect of renal disease on renal uptake and excretion of insulin in man. N. Engl. J. Med., 282, 182CrossRefGoogle Scholar
  213. 213.
    Hampers, C. L., Lowrie, E. G., Soeldner, J. S. and Merrill, J. P. (1970). The effect of uremia upon glucose metabolism. Arch. Intern. Med., 126, 870CrossRefPubMedGoogle Scholar
  214. 214.
    Bagdade, J. D. (1976). Hyperlipidemia. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis, pp. 230–240. (Springfield, Ill.: C. C. Thomas)Google Scholar
  215. 215.
    Fredrickson, D. S., Levy, R. I. and Lees, R. S. (1967). Fat transport in lipoproteins—an integrated approach to mechanisms and disorders. N. Engl. J. Med., 276, 34CrossRefPubMedGoogle Scholar
  216. 216.
    Albrink, M. J. and Man, E. B. (1959). Serum triglycerides in coronary artery disease. Arch. Intern. Med., 103, 4CrossRefGoogle Scholar
  217. 217.
    Losowsky, M. and Kenward, D. H. (1968). Lipid metabolism in acute and chronic renal failure. J. Lab. Clin. Med., 71, 736PubMedGoogle Scholar
  218. 218.
    Carlson, L. A. and Bottinger, L. E. (1972). Ischemic heart disease in relation to fasting values of plasma triglycerides and cholesterol: Stockholm prospective study. Lancet, 1, 865CrossRefPubMedGoogle Scholar
  219. 219.
    Salel, A. F., Riggs, K., Mason, D. T., Amsterdam, E. A. and Zelis, R. (1974). The importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery disease. Am. J. Med., 57, 897CrossRefPubMedGoogle Scholar
  220. 220.
    Bagdade, J. D., Porte, D. Jr. and Biermann, E. L. (1968). Hypertriglyceridemia: a metabolic consequence of chronic renal failure. N. Engl. J. Med., 279, 181CrossRefPubMedGoogle Scholar
  221. 221.
    Bagdade, J. D. (1970). Uremic lipemia. Arch. Intern. Med., 126, 875CrossRefPubMedGoogle Scholar
  222. 222.
    Bagdade, J. D. (1975). Atherosclerosis in patients undergoing maintenance hemodialysis. Kidney Int., 7 (Suppl. 3), S-370Google Scholar
  223. 223.
    Erslev, A. J. (1970). Anemia of chronic renal disease. Arch. Intern. Med., 126, 774CrossRefPubMedGoogle Scholar
  224. 224.
    Kasanen, A. and Kalliomaki, J. L. (1957). Correlation of some kidney function tests with hemoglobin in chronic nephropathies. Acta Med. Scand., 158, 213CrossRefPubMedGoogle Scholar
  225. 225.
    Desforges, J. F. and Dawson, J. P. (1958). The anemia of renal failure. Arch. Intern. Med., 101, 326CrossRefGoogle Scholar
  226. 226.
    Joske, R. A., McAlister, J. M. and Prankerd, T. A. J. (1956). Isotope investigation of red cell production and destruction in chronic renal disease. Clin. Sci., 15, 511PubMedGoogle Scholar
  227. 227.
    Loge, J. P., Lange, R. D. and Moore, C. V. (1958). Characterization of the anemia associated with chronic renal insufficiency. Am. J. Med., 24, 4CrossRefPubMedGoogle Scholar
  228. 228.
    Erslev, A. J. and Shapiro, S. S. (1979). Hematologic aspects of renal failure. In Earley, L. E. and Gottschalk, C. W. (eds.) Strauss and Welt’s Diseases of the Kidney. 3rd Edn., pp. 227–306. (Boston: Little, Brown and Company)Google Scholar
  229. 229.
    O’Brien, R. T. and Pearson, H. A. (1978). Hematologic disturbances in uremia. In Edelman, C. M. (ed.) Pediatric Kidney Disease, pp. 401–407. (Boston: Little, Brown and Company)Google Scholar
  230. 230.
    Callen, I. R. and Limarzi, L. R. (1950). Blood and bone marrow studies in renal disease. Am. J. Clin. Pathol, 20, 3PubMedGoogle Scholar
  231. 231.
    Magid, E. and Hilden, M. (1967). Ferrokinetics in patients suffering from chronic renal disease and anemia. Scand. J. Haematol., 4, 33CrossRefPubMedGoogle Scholar
  232. 232.
    Erslev, A. J. (1955). Physiologic control of red cell production. Blood, 10, 954PubMedGoogle Scholar
  233. 233.
    Jacobson, L. O., Goldwasser, E., Gumey, C. W., Fried, W. and Plzak, L. (1959). Studies on erythropoietin: the hormone regulating red cell production. Ann. NY Acad. Sci., 77, 551CrossRefPubMedGoogle Scholar
  234. 234.
    Erslev, A. J. (1959). The effect of anemic anoxia on the cellular development of nucleated red cells. Blood, 14, 386Google Scholar
  235. 235.
    Erslev, A. J. (1964). Erythropoietin in vitro. II. Effect on ‘stem cells’. Blood, 24, 331PubMedGoogle Scholar
  236. 236.
    Glass, J., Lavidor, L. M. and Robinson, S. H. (1975). Use of cell separation and short-time culture techniques to study erythroid cell development. Blood, 46, 705PubMedGoogle Scholar
  237. 237.
    Erslev, A. J. (1975). Renal biogenesis of erythropoietin. Am J. Med., 58, 25CrossRefPubMedGoogle Scholar
  238. 238.
    Fisher, J. W., Busuttil, R., Rodgers, G. M., Mujovic, V., Paulo, L., Fink, G. and George, W. J. (1975). The kidney and erythropoietin production: a review. In Nakao, K., Fisher, J. W. and Takaku, F. (eds.) Erythropoiesis, p. 315. (Tokyo: University Tokyo Press)Google Scholar
  239. 239.
    Hirashima, K. and Takaku, F. (1962). Experimental studies on erythropoietin. II. The relationship between juxtaglomerular cells and erythropoietin. Blood, 20, 1PubMedGoogle Scholar
  240. 240.
    Goldfarb, B. and Tobian, L. (1963). Relationship of erythropoietin to renal juxtaglomerular cells. Proc. Soc. Exp. Biol. Med., 112, 65PubMedGoogle Scholar
  241. 241.
    Demopoulos, H. B., Highman, B., Altland, P. D., Gerving, M. A. and Kaley, G. (1965). Effects of high altitude on granular juxtaglomerular cells and their possible role in erythropoietin production. Am. J. Pathol., 46, 497PubMedGoogle Scholar
  242. 242.
    Busuttil, R. W., Roh, B. L. and Fisher, J. W. (1971). Cytological localization of erythropoietin in the human kidney using the fluorescent antibody technique. Proc. Soc. Exp. Biol. Med., 137, 327PubMedGoogle Scholar
  243. 243.
    Busuttil, R. W., Roh, B. L. and Fisher, J. W. (1972). Further evidence of a site of production of erythropoietin in the hypoxic dog kidney. Acta Haematol., 47, 238CrossRefPubMedGoogle Scholar
  244. 244.
    Gordon, A. S., Cooper, G. W. and Zanjani, E. D. (1967). The kidney and erythropoiesis. Semin. Hematol., 4, 337PubMedGoogle Scholar
  245. 245.
    Peschle, C., Marone, G., Genovese, A., Quattrin, S. and Condorelli, M. (1975). Studies on the erythrogenin-erythropoietin system. In Nakao, K., Fisher, J. W. and Takaku, F. (eds.) Erythropoiesis, p. 241. (Tokyo: University Tokyo Press)Google Scholar
  246. 246.
    Erslev, A. J. (1974). In vitro production of erythropoietin by kidneys perfused with a serum-free solution. Blood, 44, 77PubMedGoogle Scholar
  247. 247.
    Bozzini, C. E., Devoto, F. C. H. and Tonio, J. M. (1966). Decreased responsiveness of hematopoietic tissue to erythropoietin in acutely uremic rats. J. Lab. Clin. Med., 68, 411PubMedGoogle Scholar
  248. 248.
    Van Dyke, D., Keighley, G. and Lawrence, J. (1963). Decreased responsiveness to erythropoietin in a patient with anemia secondary to chronic uremia. Blood, 22, 838Google Scholar
  249. 249.
    Fisher, J. W., Hatch, F. E., Roh, B. L., Allen, R. C. and Kelley, B. J. (1968). Erythropoietin inhibitors in kidney extracts and plasma from anemic uremic human subjects. Blood, 31, 440PubMedGoogle Scholar
  250. 250.
    Erslev, A. J. (1975). The effect of uremic toxins on the production and metabolism of erythropoietin. Kidney Int., Suppl. 2, S-129Google Scholar
  251. 251.
    Zucker, S., Lysik, R. M. and Mohammad, G. (1976). Erythropoiesis in chronic renal disease. J. Lab. Clin. Med., 88, 528PubMedGoogle Scholar
  252. 252.
    Fried, W. (1972). The liver as a source of extrarenal erythropoietin production. Blood, 40, 671PubMedGoogle Scholar
  253. 253.
    Peschle, C., Marone, G., Genovese, A., Rappaport, J. A. and Condorelli, M. (1976). Increased erythropoietin production in anephric rats with hyperplasia of the reticuloendothelial system induced by colloidal carbon or zymosan. Blood, 47, 325PubMedGoogle Scholar
  254. 254.
    Tyler, H. R. (1968). Neurologic disorders in renal failure. Am. J. Med., 44, 734CrossRefPubMedGoogle Scholar
  255. 255.
    Tyler, H. R. (1971). Neurologic complications of uremia. In Strauss, M. B. and Welt, L. G. (eds.) Diseases of the Kidney. 2nd Edn., pp. 335–342. (Boston: Little, Brown and Company)Google Scholar
  256. 256.
    Teschan, P. E. and Ginn, H. E. (1976). The nervous system. In Massry, S. G. and Sellers, A. (eds.) Clinical Aspects of Uremia and Dialysis, pp. 3–33. (Springfield, Ill.: C. C. Thomas)Google Scholar
  257. 257.
    Martinez, W. C., Rapin, I. and Moore, C. L. (1978). Neurologic complications of renal failure. In Edelman, C. M. (ed.) Pediatric Kidney Disease, pp. 408–421. (Boston: Little, Brown and Company)Google Scholar
  258. 258.
    Klinger, M. (1954). EEG observations in uremia. Electroencephalogr. Clin. Neurophysiol., 6, 519Google Scholar
  259. 259.
    Kiley, J. E. and Hines, O. (1965). EEG evaluation of uremia: wave frequency evaluation on 40 uremic patients. Arch. Intern. Med., 116, 67CrossRefPubMedGoogle Scholar
  260. 260.
    Hampers, C. L., Doak, P. B., Callaghan, M. D., Tyler, H. R. and Merrill, J. P. (1966). The EEG and spinal fluid during hemodialysis. Arch. Intern. Med., 118, 340CrossRefPubMedGoogle Scholar
  261. 261.
    Depner, T. A. and Gulyassy, P. F. (1979). Chronic renal failure. In Earley, L. E. and Gottschalk, C. W. (eds.) Strauss and Welt’s Disease of the Kidney. 3rd Edn., pp. 211–261. (Boston: Little, Brown and Company)Google Scholar
  262. 262.
    Cuttelod, S. (1974). Effect of age and role of kidneys and liver on thyrotropin turnover in man. Metabolism, 23, 101CrossRefPubMedGoogle Scholar
  263. 263.
    Asbury, A. K., Victor, N. and Adams, R. D. (1962). Uremic polyneuropathy. Trans. Am. Neurol. Assoc, 87, 100PubMedGoogle Scholar
  264. 264.
    Asbury, A. K., Victor, M. and Adams, R. D. (1963). Uremic polyneuropathy. Arch. Neurol., 8, 413CrossRefPubMedGoogle Scholar
  265. 265.
    Callaghan, N. (1966). Restless legs syndrome in uremic neuropathy. Neurology, 16, 359PubMedGoogle Scholar
  266. 266.
    Nielsen, V. K. (1971). The peripheral nerve function in chronic renal failure. Acta Med. Scand., 190, 105CrossRefPubMedGoogle Scholar
  267. 267.
    Thomas, O. K. (1976). Uraemic neuropathy. Proc. Eur. Dial. Transplant. Assoc, 13, 109Google Scholar
  268. 268.
    Freeman, R. B., Sheff, M. F., Maher, J. F. and Schreiner, G. E. (1962). The blood cerebrospinal fluid barrier in uremia. Ann. Intern. Med., 56, 233PubMedGoogle Scholar
  269. 269.
    Triger, D. R. and Jockes, A. M. (1969). Severe muscle cramps due to acute hypo-magnesemia in haemodialysis. Br. Med. J., 2, 804CrossRefPubMedGoogle Scholar
  270. 270.
    Arieff, A. I. and Massry, S. G. (1976). Dialysis disequilibrium syndrome. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis, pp. 34–52. (Springfield, Ill.: C. C. Thomas)Google Scholar
  271. 271.
    Caruso, G., Spadetta, V. and Labianca, O. (1970). Subclinical uremic neuropathy. In Walton, J. N., Canel, N. and Scarlato, G. (eds.) Muscle Diseases, p. 173. (Amsterdam: Excerpta Medica)Google Scholar
  272. 272.
    Cavanagh, J. B. (1964). The significance of the ‘dying back’ process in experimental and human neurological disease. Int. Rev. Exp. Pathol., 3, 219PubMedGoogle Scholar
  273. 273.
    Forno, L. and Alston, W. (1967). Uremic polyneuropathy. Acta Neurol. Scand., 43, 640CrossRefPubMedGoogle Scholar
  274. 274.
    Kornfeld, M. and Appenzeller, O. (1970). Pathology of sural nerve in uremic neuropathy. In Proceedings V Congress of Neuropathology (Paris)Google Scholar
  275. 275.
    Dinn, J. J. and Crame, D. L. (1970). Schwann cell disfunction in uraemia. J. Neurol. Neurosurg. Psychiatry, 33, 605CrossRefPubMedGoogle Scholar
  276. 276.
    Thomas, P. K., Hollinrake, K., Lascelles, R. G., O’Sullivan, D. J., Baillod, R. A., Moorhead, J. F. and Mackenzie, J. C. (1971). The polyneuropathy of chronic renal failure. Brain, 94, 761CrossRefPubMedGoogle Scholar
  277. 277.
    Dyck, P. I., Johnson, W. I., Lambert, E. H. and O’Brien, P. C. (1971). Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin. Proc., 46, 400PubMedGoogle Scholar
  278. 278.
    Nielsen, V. K. (1974). The peripheral nerve function in chronic renal failure. X. Decrementai nerve conduction in uremia? Acta Med. Scand., 196, 83CrossRefPubMedGoogle Scholar
  279. 279.
    Nielsen, V. K. (1974). The peripheral nerve function in chronic renal failure. IX. Recovery after renal transplantation. Electrophysiological aspects (sensory and motor nerve conduction). Acta Med. Scand., 195, 171CrossRefPubMedGoogle Scholar
  280. 280.
    Caruso, G., Santoro, L., Peretti, A., Serlenga, L., Usberti, M. and Andreucci, V. E. (1978). Uremic polyneuropathy: electrophysiological and histopathological aspects. Dial. Transplant., 7, 320Google Scholar
  281. 281.
    Thomas, P. K. (1971). The morphological basis for alteration in nerve conduction in peripheral neuropathy. Proc. R. Soc. Med., 64, 295PubMedGoogle Scholar
  282. 282.
    Andreucci, V. E., Usberti, M., Calderaro, V., Federico, S., Santoro, L. and Caruso, G. (1978). The need for dialysis. Dial. Transplant., 7, 313Google Scholar
  283. 283.
    Weidman, P. and Maxwell, M. H. (1976). Hypertension. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis, pp. 100–145. (Springfield, Ill.: C. C. Thomas)Google Scholar
  284. 284.
    Davidson, R. C. and Scribner, B. H. (1979). Cardiovascular manifestations of renal failure. In Earley, L. E. and Gottschalk, C. W. (eds.) Strauss and Welt’s Diseases of the Kidney. 3rd Edn., pp. 263–275. (Boston: Little, Brown and Company)Google Scholar
  285. 285.
    Ledingham, J. H. and Cohen, R. D. (1964). Changes in the extracellular fluid volume and cardiac output during the development of experimental renal hypertension. Can. Med. Assoc. J., 90, 292PubMedGoogle Scholar
  286. 286.
    Coleman, T. G., Bower, J. D., Langford, H. G. and Guyton, A. C. (1970). Regulation of arterial pressure in the anephric state. Circulation, 42, 509PubMedGoogle Scholar
  287. 287.
    Guyton, A. C., Coleman, T. G., Cowley, A. W. Jr., Scheel, K. W., Manning, R. D. Jr. and Norman, R. A. Jr. (1972). Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and hypertension. Am. J. Med., 52, 584CrossRefPubMedGoogle Scholar
  288. 288.
    Selkurt, E. E. (1951). Effect of pulse pressure and mean arterial pressure modification on renal hemodynamics and electrolyte and water excretion. Circulation, 4, 541PubMedGoogle Scholar
  289. 289.
    Koch, K. M., Aynedjian, H. S. and Bank, N. (1968). Effect of acute hypertension on sodium reabsorption by the proximal tubule. J. Clin. Invest., 47, 1969CrossRefGoogle Scholar
  290. 290.
    Bank, N. E., Koch, K. M., Aynedjian, H. S. and Aras, M. (1969). Effect of changes in renal perfusion pressure on the suppression of proximal tubular sodium reabsorption due to saline loading. J. Clin. Invest., 48, 271CrossRefPubMedGoogle Scholar
  291. 291.
    Aperia, A. C., Broberger, C. G. O. and Soderlund, S. (1971). Relationship between renal artery perfusion pressure and tubular sodium reabsorption. Am. J. Physiol., 220, 1205PubMedGoogle Scholar
  292. 292.
    Navar, L. G. (1972). Distal nephron diluting segment responses to altered arterial pressure and solute loading. Am. J. Physiol., 22, 945Google Scholar
  293. 293.
    Borst, J. G. and Borst-de Geus, A. (1963). Hypertension explained by Starling’s theory of circulatory homeostasis. Lancet, 2, 677CrossRefGoogle Scholar
  294. 294.
    Ulvila, J. M., Kennedy, J. A., Lamberg, J. D. and Scribner, B. H. (1972). Blood pressure in chronic renal failure: effect of sodium intake and furosemide. J. Am. Med. Assoc., 220, 233CrossRefGoogle Scholar
  295. 295.
    Tobian, L. Jr., Olson, R. and Chesley, G. (1969). Water content of arteriolar wall in renovascular hypertension. Am. J. Physiol., 216, 22PubMedGoogle Scholar
  296. 296.
    Sivertsson, R. (1970). The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol. Scand. (Suppl.), 343, 1Google Scholar
  297. 297.
    Folkow, B. (1971). The hemodynamic consequences of adaptive structural changes of the resistance vessels in hypertension. Clin. Sci., 41, 1PubMedGoogle Scholar
  298. 298.
    Tobian, L. Jr. (1972). A viewpoint concerning the enigma of hypertension. Am. J. Med., 52, 595CrossRefPubMedGoogle Scholar
  299. 299.
    Seidel, C. L. and Bohr, D. F. (1971). Calcium and vascular smooth muscle contraction. Circ. Res., 28 and 29 (Suppl. 11), 88PubMedGoogle Scholar
  300. 300.
    Brunner, H. R., Chang, P., Wallach, R., Sealey, J. E. and Laragh, J. H. (1972). Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system and hypertension. J. Clin. Invest., 51, 58CrossRefPubMedGoogle Scholar
  301. 301.
    Symonds, E. M., Stanley, M. A. and Skinner, S. L. (1968). Production of renin by in vitro cultures of human chorion and uterine muscle. Nature (London), 217, 1152CrossRefGoogle Scholar
  302. 302.
    Ganten, D., Hayduk, K., Brecht, H. M., Boucher, R. and Genest, J. (1970). Evidence of renin release or production in splanchnic territory. Nature (London), 226, 551CrossRefGoogle Scholar
  303. 303.
    Vertes, V., Cangiano, J. L., Berman, L. B. and Gould, A. (1969). Hypertension in end-stage renal disease. N. Engl. J. Med., 280, 978CrossRefPubMedGoogle Scholar
  304. 304.
    Stokes, G. S., Mani, M. K. and Stewart, J. H. (1970). Relevance of salt, water and renin to hypertension in chronic renal failure. Br. Med. J., 3, 126CrossRefPubMedGoogle Scholar
  305. 305.
    Wilkinson, R., Scott, D. F., Uldall, P. R., Kerr, D. N. S., Swinney, J. and Robson, V. (1970). Plasma renin and exchangeable sodium in the hypertension of chronic renal failure. The effect of bilateral nephrectomy. Q.J. Med., 39, 377PubMedGoogle Scholar
  306. 306.
    Kotchen, T. A., Knight, E. L., Kashgarian, M. and Mulrow, P. J. (1970). A study of the renin-angiotensin system in patients with severe chronic renal insufficiency. Nephron, 7, 317CrossRefPubMedGoogle Scholar
  307. 307.
    Brown, J. J., Dusterdieck, G., Fraser, R., Lever, A. F., Robertson, J. I. S., Tree, M. and Weir, R. J. (1971). Hypertension and chronic renal failure. Br. Med. Bull, 27, 128PubMedGoogle Scholar
  308. 308.
    Weidmann, P., Maxwell, M. H., Lupu, A. N., Lewin, A. J. and Massry, S. G. (1971). Plasma renin activity and blood pressure in terminal renal failure. N. Engl. J. Med., 285, 757CrossRefPubMedGoogle Scholar
  309. 309.
    Medina, A., Bell, P. R. F., Briggs, J. D., Brown, J. J., Fine, A., Lever, A. F., Morton, J. J., Paton, A. M., Robertson, J. I. S., Tree, M., Waite, M. A., Weir, R. and Winchester, J. (1972). Changes in blood pressure, renin and angiotensin after bilateral nephrectomy in patients with chronic renal failure. Br. Med. J., 4, 694CrossRefPubMedGoogle Scholar
  310. 310.
    Lazarus, J. M., Hampers, C. L., Bennett, A. H., Vandam, L. D. and Merrill, J. P. (1972). Urgent bilateral nephrectomy for severe hypertension. Ann. Intern. Med., 76, 733PubMedGoogle Scholar
  311. 311.
    Mahoney, J. F., Gibson, G. R., Sheil, A. G. R., Storey, B. G., Stokes, G. S. and Stewart, J. H. (1972). Bilateral nephrectomy for malignant hypertension. Lancet, 1, 1036CrossRefGoogle Scholar
  312. 312.
    Lee, J. B., Covino, B. G., Takman, B. H. and Smith, E. R. (1965). Renomedullary vasodepressor substance medullin: isolation, chemical characterization, and physiological properties. Circ. Res., 17, 57PubMedGoogle Scholar
  313. 313.
    Higgins, C. B., Vatner, S. F., Franklin, D., Patrick, T. and Braunwald, E. (1971). Effects of prostaglandin A, on the systemic and coronary circulations in the conscious dog. Circ. Res., 28, 638PubMedGoogle Scholar
  314. 314.
    Carr, A. A. (1970). Hemodynamic and renal effects of a prostaglandin, PGAt in subjects with essential hypertension. Am. J. Med. Sci., 259, 21CrossRefPubMedGoogle Scholar
  315. 315.
    Westura, E. E., Kannegiesser, H., O’Toole, J. D. and Lee, J. B. (1970). Antihypertensive effects of prostaglandin A x in essential hypertension. Circ. Res., 27 (Suppl.), 131PubMedGoogle Scholar
  316. 316.
    Lee, J. B., McGiff, J. C., Kannegiesser, H., Aykent, Y. Y., Mudd, G. and Frawley, T. F. (1971). Prostaglandin A1: antihypertensive and renal effects. Ann. Intern. Med., 74, 703PubMedGoogle Scholar
  317. 317.
    Lee, S. J., Johnson, J. G., Smith, C. J. and Hatch, F. E. (1972). Renal effects of prostaglandin A1 (PGA1) on renal and adrenal function in man. Circ. Res., 31 (Suppl.), 19Google Scholar
  318. 318.
    Fichman, M. P., Littenberg, G., Brooker, G. and Horton, R. (1972). The effect of prostaglandin A1 (PGA1) on renal and adrenal function in man. Circ. Res., 31 (Suppl.), 19PubMedGoogle Scholar
  319. 319.
    Kaplan, N. M. (1978). Clinical Hypertension. 2nd End., p. 405. (Baltimore, MD: The Williams & Wilkins Co.)Google Scholar
  320. 320.
    Pabico, R. C. and Freeman, R. B. (1976). Pericarditis and myocardiopathy. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis, pp. 69–99. (Springfield, Ill.: C. C. Thomas)Google Scholar
  321. 321.
    D’Cruz, I. A., Bhatt, G. R., Cohen, H. C. and Glick, G. (1978). Echocardiographic detection of cardiac involvement in patients with chronic renal failure. Arch. Intern. Med., 138, 720CrossRefPubMedGoogle Scholar
  322. 322.
    Gibson, D. G. (1966). Hemodynamic factors in the development of acute pulmonary edema in renal failure. Lancet, 2, 1217CrossRefPubMedGoogle Scholar
  323. 323.
    Parisi, A. F., Tow, D. E., Felix, W. R. Jr. and Sasahara, A. A. (1977). Non-invasive cardiac diagnosis. (Third of three parts.) N. Engl. J. Med., 296, 427CrossRefPubMedGoogle Scholar
  324. 324.
    Horowitz, M. S., Schultz, C. S., Stinson, E. B., Harrison, D. C. and Popp, R. L. (1974). Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation, 50, 239PubMedGoogle Scholar
  325. 325.
    Edwards, K. D. G. and Whyte, H. M. (1959). Plasma creatinine level and creatinine as tests of renal function. Aust. Ann. Med., 8, 218PubMedGoogle Scholar
  326. 326.
    Jeliffe, R. W. (1971). Estimation of creatinine clearance when urine cannot be collected. Lancet, 1, 975CrossRefGoogle Scholar
  327. 327.
    Cockcroft, D. W. and Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31CrossRefPubMedGoogle Scholar
  328. 328.
    Hamburger, J., Richet, G., Crosnier, J., Funck-Brentano, J. L., Antoine, B., Ducrot, H., Mery, J. P., De Montera, H. and Royer, P. (1966). Nephrologie. (Paris: Flammarion)Google Scholar
  329. 329.
    Goldsmith, D. I. (1978). Clinical and laboratory evaluation of renal function. In Edelmann, C. M. Jr. (ed.), Pediatric Kidney Disease, pp. 213–224. (Boston: Little, Brown and Company)Google Scholar
  330. 330.
    Rosenthall, L. (1966). Orthoiodohippurate I131 kidney scanning in renal failure. Radiology, 87, 298PubMedGoogle Scholar
  331. 331.
    Freeman, L. M., Goldman, S. M., Shaw, R. K. and Blaufox, M. D. (1969). Kidney visualization with 131I-orthoiodohippurate in patients with renal insufficiency. J. Nucl. Med., 10, 545PubMedGoogle Scholar
  332. 332.
    Schoutens, A., Dupuis, F. and Toussaint, C. (1972). 131I-hippuran scanning in severe renal failure. Nephron, 9, 275CrossRefPubMedGoogle Scholar
  333. 333.
    Reba, R. C., Poulose, K. P. and Kirchner, P. T. (1974). Radiolabeled chelates for visualization of kidney function and structure with emphasis on their use in renal insufficiency. Semin. Nucl. Med., 4, 151CrossRefPubMedGoogle Scholar
  334. 334.
    Sanders, R. C. and Jeck, D. L. (1976). B-scan ultrasound in the evaluation of renal failure. Radiology, 119, 199PubMedGoogle Scholar
  335. 335.
    Baum, G. (1974). Applications of ultrasound. J. Am. Med. Assoc, 229, 1065CrossRefGoogle Scholar
  336. 336.
    Koenigsberg, M., Freeman, L. M. and Blaufox, M. D. (1978). Radionuclide and ultrasound evaluation of renal morphology and function. In Edelmann, C. M. Jr. (ed.), Pediatric Kidney Disease, pp. 236–261. (Boston: Little, Brown and Company)Google Scholar
  337. 337.
    Ferrucci, J. T. Jr. (1979). Body ultrasonography. N. Engl. J. Med., 300, 538 and 590CrossRefPubMedGoogle Scholar
  338. 338.
    Sanders, R. C. and Bearman, S. (1973). B-scan ultrasound in the diagnosis of hydronephrosis. Radiology, 108, 375PubMedGoogle Scholar
  339. 339.
    Hasch, E. (1974). Ultrasound in the diagnosis of hydronephrosis in infants and children. J. Clin. Ultrasound, 2, 21CrossRefPubMedGoogle Scholar
  340. 340.
    Sanders, R. O and Conrad, M. R. (1977). The ultrasonic characteristics of the renal pelvicalyceal echo complex. J. Clin. Ultrasound, 5, 372CrossRefPubMedGoogle Scholar
  341. 341.
    Pollack, H. M., Arger, P. H., Goldberg, B. B. and Mulholland, S. G. (1978). Ultrasonic detection of non-opaque renal calculi. Radiology, 127, 233PubMedGoogle Scholar
  342. 342.
    Edell, S. and Zegel, H. (1978). Ultrasonic evaluation of renal calculi. Am J. Roentgenol. Radium Ther. Nucl. Med., 130, 261Google Scholar
  343. 343.
    Giordano, C. (1963). Use of exogenous and endogenous urea for protein synthesis in normal and uremic subjects. J. Lab. Clin. Med., 62, 231PubMedGoogle Scholar
  344. 344.
    Giovannetti, S. and Maggiore, Q. (1964). A low nitrogen diet with proteins of high biological value for severe chronic uraemia. Lancet, 1, 1000CrossRefPubMedGoogle Scholar
  345. 345.
    Schloerb, P. R. (1966). Essential L-amino acid administration in uremia. Am. J. Med. Sci., 252, 650CrossRefPubMedGoogle Scholar
  346. 346.
    Richards, P., Metcalfe-Gibson, A., Ward, E. E., Wrong, O. and Houghton, B. J. (1967). Utilisation of ammonia nitrogen for protein synthesis in man, and the effect of protein restriction and uraemia. Lancet, 2, 845CrossRefPubMedGoogle Scholar
  347. 347.
    Varcoe, R., Halliday, D., Carson, E. R., Richards, P. and Tavill, A. S. (1975). Efficiency of utilization of urea nitrogen for albumin synthesis by chronically uraemic and normal man. Clin. Sci. Mol. Med., 48, 379PubMedGoogle Scholar
  348. 348.
    Walser, M. (1978). Keto-analogues of essential amino acids in the treatment of chronic renal failure. Kidney Int., 13 (Suppl. 8), S-180Google Scholar
  349. 349.
    Walser, M. (1975). Ketoacids in the treatment of uremia. Clin. Nephrol., 3, 180PubMedGoogle Scholar
  350. 350.
    Cohen, B. D. (1978). Disturbances of nitrogen, carbohydrate and lipid metabolism. In Edelmann, C. M. (ed.) Pediatric Kidney Disease, pp. 432–442. (Boston: Little, Brown and Company)Google Scholar
  351. 351.
    Kopple, J. D. (1976). Dietary requirements. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis, pp. 453–489. (Springfield, Ill.: C. C. Thomas)Google Scholar
  352. 352.
    Kopple, J. D. (1978). Nutritional management of chronic renal failure. Postgrad. Med., 64, 135PubMedGoogle Scholar
  353. 353.
    Anderson, C. F., Nelson, R. A., Margie, J. D., Johnson, W. J. and Hunt, J. C. (1973). Nutritional therapy for adults with renal disease. J. Am. Med. Assoc, 223, 68CrossRefGoogle Scholar
  354. 354.
    Hyne, B. E. B., Fowell, E. and Lee, H. A. (1972). The effect of caloric intake on nitrogen balance in chronic renal failure. Clin. Sci., 43, 679PubMedGoogle Scholar
  355. 355.
    Gulyassy, P. F., Yamauchi, H. and Depner, T. A. (1979). Conservative management of chronic renal failure. In Earley, L. E. and Gottschalk, C. W. (eds.) Strauss and Welt’s Diseases of the Kidney. 3rd Edn., pp. 395–420. (Boston: Little, Brown and Company)Google Scholar
  356. 356.
    Margie, J. D., Anderson, C. F., Nelson, R. A. and Hunt, J. C. (1974). The Mayo Clinic Diet Cookbook. (New York: Golden Press)Google Scholar
  357. 357.
    David, D. S., Rubin, A. L., Hochgelerent, E. and Stenzel, K. H. (1972). Dietary management in renal failure. Lancet, 1, 34CrossRefGoogle Scholar
  358. 358.
    Broyer, M. (1974). Renal failure and arterial hypertension. Chronic renal failure. In Royer, P., Habib, R., Mathieu, H. and Broyer, M. (eds.) Pediatric Nephrology. Part IV, pp. 371–377. (Philadelphia: Saunders)Google Scholar
  359. 359.
    Aronson, A., Fürst, S., Kuylenstierna, P. and Nyberg, G. (1975). Essential amino acids in the treatment of advanced uremia: twenty-two months’ experience in a five-year-old girl. Pediatrics, 56, 538PubMedGoogle Scholar
  360. 360.
    Kopple, J. D., Sorensen, M. K., Coburn, J. W., Gordon, S. and Rubini, M. E. (1968). Controlled comparison of 20-g and 40-g protein diets in the treatment of chronic uremia. Am. J. Clin. Nutr., 21 553PubMedGoogle Scholar
  361. 361.
    Kopple, J. D., Shinaberger, J. H., Coburn, J. W., Sorensen, M. K. and Rubini, M. E. (1969). Evaluating modified protein diets for uremia. J. Am. Diet. Assoc, 54, 481PubMedGoogle Scholar
  362. 362.
    Sorensen, M. K. and Kopple, J. D. (1968). Assessment of adherence to protein-restricted diets during conservative management of uremia. Am. J. Clin. Nutr., 21, 631PubMedGoogle Scholar
  363. 363.
    Kopple, J. D. and Coburn, J. W. (1974). Evaluation of chronic uremia. J. Am. Med. Assoc, 227, 41CrossRefGoogle Scholar
  364. 364.
    Kopple, J. D. and Swendseid, M. E. (1977). Amino acid and keto acid diets for therapy in renal failure. Nephron, 18, 1CrossRefPubMedGoogle Scholar
  365. 365.
    Kopple, J. D. and Swendseid, M. E. (1974). Nitrogen balance and plasma amino acids levels in uremic patients fed an essential amino acid diet. Am. J. Clin. Nutr., 27, 806PubMedGoogle Scholar
  366. 366.
    Noree, L. O. and Bergstrom, J. (1975). Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. II. Clinical results of long-term treatment. Clin. Nephrol., 3, 195PubMedGoogle Scholar
  367. 367.
    Walser, M., Coulter, A. W., Dighe, S. and Crantz, F. R. (1973). The effect of keto-analogues of essential amino acids in severe chronic uremia. J. Clin. Invest., 52, 678CrossRefPubMedGoogle Scholar
  368. 368.
    Rose, W. C. (1957). The amino acid requirements of an adult man. Nutr. Rev., 27, 631Google Scholar
  369. 369.
    Kopple, J. D. (1978). Treatment with low protein and amino acid diets in chronic renal failure. In Proceedings VII International Congress of Nephrology (Montreal, June 18–23, 1978), pp. 497–507. (Basel: S. Karger)Google Scholar
  370. 370.
    Chantier, C. and Holliday, M. A. (1973). Growth in children with renal disease, with particular reference to the effects of calorie malnutrition: a review. Clin. Nephrol., 1, 230Google Scholar
  371. 371.
    Betts, P. R. and Magrath, G. (1974). Growth pattern and dietary intake of children with chronic renal insufficiency. Br. Med. J., 2, 189CrossRefPubMedGoogle Scholar
  372. 372.
    Diaz, M., Kleinknecht, C. and Broyer, M. (1975). Growth in experimental renal failure. Incidence of calorie and amino acid intake. Kidney Int., 8, 349CrossRefPubMedGoogle Scholar
  373. 373.
    Scharer, K. (1978). Growth in children with chronic renal failure. Kidney Int., 13 (Suppl. 8), S-68Google Scholar
  374. 374.
    Abitrol, C. L. and Holliday, M. A. (1978). The effect of energy and nitrogen intake upon urea production in children with uremia and undernutrition. Clin. Nephrol., 10, 9Google Scholar
  375. 375.
    Kerr, D., Ashworth, A., Picou, D., Poulter, N., Seakin, A., Spady, D. and Wheeler, E. (1973). Accelerated recovery from infant malnutrition with high calorie feeding. In Gardner, L. L. and Amacher, P. (eds.) Endocrine Aspects of Malnutrition, pp. 467–479. (Santa Ynez: Kroc Foundation)Google Scholar
  376. 376.
    Abitbol, C. and Holliday, M. A. (1974). Nitrogen-sparing effect of essential amino acids in uremia. Kidney Int., 6, 15ACrossRefGoogle Scholar
  377. 377.
    Giordano, C., De Santo, N. G., Di Toro, R., Pluvio, M. and Perrone, L. (1978). Amino acid and keto acid diet in uremic children and infants. Kidney Int., 13 (Suppl. 8), S-83Google Scholar
  378. 378.
    Fürst, P., Bergstrom, J. and Norée, L. O. (1975). Treatment of chronic uremic patients with protein poor diet and oral supply of essential amino acids. Clin. Nephrol., 3, 187PubMedGoogle Scholar
  379. 379.
    Holt, E. and Snyderman, S. (1961). The amino acid requirements of infants. J. Am. Med. Assoc, 175, 125CrossRefGoogle Scholar
  380. 380.
    Bergstrom, J., Fürst, P., Josephson, B. and Norée, L. (1970). Improvement of nitrogen balance in a uremic patient by the addition of histidine to essential amino acid solutions given intravenously. Life Sci., 9, 787CrossRefGoogle Scholar
  381. 381.
    Fürst, P. (1972). Studies in severe renal failure. II. Evidence for the essentiality of histidine. Scand. J. Clin. Lab. Invest., 30, 307CrossRefPubMedGoogle Scholar
  382. 382.
    Walser, M., Mitch, W. E. and Collier, V. U. (1978). Effects of protein restriction plus keto analogues of essential amino acids of the course of chronic renal failure. In Proceedings VII International Congress of Nephrology (Montreal, June 18–23, 1978), pp. 483–487. (Basel: S. Karger)Google Scholar
  383. 383.
    Collier, V. U., Mitch, W. E. and Walser, M. (1978). The effect of spontaneous or induced lowering of plasma Ca × P product on progression of chronic renal failure. Clin. Res., 26, 564AGoogle Scholar
  384. 384.
    Erslev, A. J. (1974). Management of the anemia of chronic renal failure. Clin. Nephrol., 2, 174PubMedGoogle Scholar
  385. 385.
    Feldman, H. A. and Singer, I. (1975). Endocrinology and metabolism in uremia. Medicine, 54, 351CrossRefGoogle Scholar
  386. 386.
    Cattran, D. C., Steiner, G., Fenton, S. S. A. and Wilson, D. R. (1974). Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis. Trans. Am. Soc. Artif. Intern. Organs, 20, 148Google Scholar
  387. 387.
    Murase, T., Cattran, D. C., Rubenstein, B. and Steiner, G. (1975). Inhibition of lipoprotein lipase by uremic plasma: a possible cause of hypertriglyceridemia. Metabolism, 24, 1279CrossRefPubMedGoogle Scholar
  388. 388.
    Sanfelippo, M. L., Swenson, R. S. and Reaven, G. M. (1977). Reduction of plasma triglycerides by diet in subjects with chronic renal failure. Kidney Int., 11, 54CrossRefPubMedGoogle Scholar
  389. 389.
    Ginsberg, H., Olefsky, J., Kimmerling, G., Crapo, P. and Reaven, G. (1976). Induction of hypertriglyceridemia by a low fat diet. J. Clin. Endocrinol. Metab., 42, 729CrossRefPubMedGoogle Scholar
  390. 390.
    Nestel, P. J., Carroll, K. F. and Havenstein, N. (1970). Plasma triglyceride response to carbohydrates, fats and calorie intake. Metabolism, 19, 1CrossRefPubMedGoogle Scholar
  391. 391.
    Grundy, S. (1975). Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. J. Clin. Invest., 55, 269CrossRefPubMedGoogle Scholar
  392. 392.
    Pierides, A. M., Alvarez-Ude, A. F. and Kerr, D. N. S. (1975). Clofibrate-induced muscle damage in patients with chronic renal failure. Lancet, 2, 1279CrossRefPubMedGoogle Scholar
  393. 393.
    Goldberg, A. P., Sherrad, D. J., Haas, L. B. and Brunzell, J. D. (1977). Control of Clofibrate toxicity in uremic hypertriglyceridemia. Clin. Pharmacol. Ther., 21, 317PubMedGoogle Scholar
  394. 394.
    Goldberg, A., Brunzell, J. and Sherrard, D. (1975). Clofibrate effective treatment for uremic hypertriglyceridemia. Kidney Int., 8, 412Google Scholar
  395. 395.
    Di Giulio, S., Boulu, R., Drueke, T., Nicolai, A., Zingraff, J. and Crosnier, J. (1977). Clofibrate treatment of hyperlipidemia in chronic renal failure. Clin. Nephrol., 8, 504PubMedGoogle Scholar
  396. 396.
    Calderaro, V., Federico, S., Conte, G., Memoli, B. and Andreucci, V. E. (1977). Treatment of uremic hypertriglyceridemia with Clofibrate. Abstracts of XIV Congress of European Dialysis and Transplant Association, May 31-June 3, Helsinki, p. 185Google Scholar
  397. 397.
    Committee of Principal Investigators (Oliver, M. F., Heady, J. A., Morris, J. N. and Cooper, H.) (1978). A co-operative trial in the primary prevention of ischaemic heart disease using Clofibrate. Br. Heart J., 40, 1069CrossRefGoogle Scholar
  398. 398.
    Oliver, M. F. (1978). Cholesterol, coronaries, Clofibrate and death. N. Engl. J. Med., 299, 1360CrossRefPubMedGoogle Scholar
  399. 399.
    Editorial (1978). Clofibrate and the primary prevention of ischaemic heart disease. Br. Med. J., 2, 1585CrossRefGoogle Scholar
  400. 400.
    Einarsson, K., Hellstrom, K. and Leijd, B. (1977). Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV. J. Lab. Clin. Med., 90, 613PubMedGoogle Scholar
  401. 401.
    Rocha, J., Davidson, R. C. and Scribner, B. H. (1972). The concept of basal sodium excretion in the management of hypertension in primary renal disease. In Onesti, G., Kim, K. E. and Mover, J. H. (eds.) Hypertension: Mechanisms and Management, pp. 791–803. (New York: Grune & Stratton)Google Scholar
  402. 402.
    Nemati, M., Kyle, M. C. and Freis, E. D. (1977). Clinical study of ticrynafen: a new diuretic, antihypertensive and uricosuric agent. J. Am. Med. Assoc, 237, 652CrossRefGoogle Scholar
  403. 403.
    Huang, C.M., Chock, D., del Greco, F., Armstrong, M., Kroc, J. and Quintanilla, A. (1979). Antihypertensive and hemodynamic effects of ticrynafen compared with hydrochlorothiazide. Nephron, 23 (Suppl. 1), 51CrossRefPubMedGoogle Scholar
  404. 404.
    Beg, M. A., Zuccarello, W., Donikian, M. A., Ragland, R. and Ziv, D. S. (1979). Renal function during ticrynafen therapy. Nephron, 23 (Suppl. 1), 64CrossRefPubMedGoogle Scholar
  405. 405.
    Bauer, J. H. and Brooks, C. S. (1979). Comparative effects of ticrynafen and hydrochlorothiazide on blood pressure, renal function, serum uric acid and electrolytes, and body fluid spaces in hypertensive man. Nephron, 23 (Suppl. 1), 57CrossRefPubMedGoogle Scholar
  406. 406.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents (1979). Comparative effects of ticrynafen and hydrochlorothiazide in the treatment of hypertension. N. Engl. J. Med., 301, 293CrossRefGoogle Scholar
  407. 407.
    Stote, R. M., Dubb, J. W., Familiar, R., Erb, B., Weiherer, S. and Alexander, F. (1979). Ticrynafen: site of natriuretic activity. Nephron, 23 (Suppl. 1), 25CrossRefPubMedGoogle Scholar
  408. 408.
    Friedman, A. and Steele, T. H. (1977). Supersaturation of urine with uric acid and monosodium urate: response to a uricosuric diuretic. Clin. Res., 25, 621Google Scholar
  409. 409.
    Lelievre, G., Raviart, B. and Lepontre, E. (1978). Insuffisance rénale aiguë lors de l’administration d’un diurétique hypouricémiant, l’acide tiénilique. Nouv. Presse Med., 7, 2654PubMedGoogle Scholar
  410. 410.
    Bennett, W. M. and Van Zee, B. E. (1979). Acute renal failure from ticrynafen. N. Engl. J. Med., 301, 1179CrossRefPubMedGoogle Scholar
  411. 411.
    Cohen, L. H., Norby, L. H., Champion, C. and Spargo, B. (1979). Acute renal failure from ticrynafen. N. Engl. J. Med., 301, 1180PubMedGoogle Scholar
  412. 412.
    Selby, T. (1979). Acute renal failure from ticrynafen. N. Engl. J. Med., 301, 1180PubMedGoogle Scholar
  413. 413.
    Ahlquist, R. P. (1948). A study of the adrenotropic receptors. Am. J. Physiol, 153, 586PubMedGoogle Scholar
  414. 414.
    Koch-Weser, J. (1979). Drug therapy. Metoprolol. N. Engl. J. Med., 301, 698CrossRefPubMedGoogle Scholar
  415. 415.
    Ablad, B., Carlsson, E. and Ek, L. (1973). Pharmacological studies of two new cardio-selective adrenergic beta-receptors antagonists. Life Sci., 12, 107CrossRefGoogle Scholar
  416. 416.
    Johnson, G., Regardh, C. G. and Solvell, L. (1975). Combined pharmacokinetic and pharmacodynamic studies in man of the adrenergic beta1-receptor antagonist metoprolol. Acta Pharmacol. Toxicol., 36 (Suppl. 5), 31Google Scholar
  417. 417.
    Brown, H. C., Carruthers, S. G., Johnston, G. D., Kelly, J. G., McAinsh, J., McDevitt, D. G. and Shanks, R. G. (1976). Clinical pharmacology of atenolol, a new beta-adreno-ceptor blocking drug. Clin. Pharmacol. Ther., 20, 524PubMedGoogle Scholar
  418. 418.
    McAinsh, J. (1977). Clinical pharmacokinetics of atenolol. Postgrad. Med. J., 53 (Suppl. 3), 74PubMedGoogle Scholar
  419. 419.
    Bengtsson, C. (1976). Comparison between metoprolol and propranolol as antihypertensive agents: a double-blind cross-over study. Acta Med. Scand., 199, 71CrossRefPubMedGoogle Scholar
  420. 420.
    Singh, A. N., Paul, L. and Elie, R. (1978). Double blind comparison clinical trial of metoprolol versus propranolol in the long-term treatment of uncomplicated hypertensive patient. Curr. Ther. Res., 24, 571Google Scholar
  421. 421.
    Zacharias, F. J., Mayes, P. J. and Cruickshank, J. M. (1977). Atenolol in hypertension: a double-blind comparison of the response to three different doses. Postgrad. Med. J., 53 (Suppl. 3), 114PubMedGoogle Scholar
  422. 422.
    Prichard, B. N. C. (1978). Beta-adrenergic receptor blockade in hypertension, past, present and future. Br. J. Clin. Pharmacol., 5, 379PubMedGoogle Scholar
  423. 423.
    Castleden, C. M., Danthan, J. R. E. and George, C. (1977). A comparison of once and twice daily atenolol in hypertension. Postgrad. Med. J., 53, 679CrossRefPubMedGoogle Scholar
  424. 424.
    Keusch, G. W., Weidmann, P., Compere, V., Lee, D. B. N., Upham, A. T. and Massry, S. G. (1978). Minoxidil therapy in refractory hypertension. Analysis of 155 patients. Nephron, 21, 1CrossRefPubMedGoogle Scholar
  425. 425.
    Mitchell, H. C. and Pettinger, W. A. (1978). Long-term treatment of refractory hypertensive patients with minoxidil. J. Am. Med. Assoc., 233, 2131CrossRefGoogle Scholar
  426. 426.
    Andreucci, V. E., Usberti, M., Federico, S., Pecoraro, C., Balletta, M. and Meccariello, S. (1981). Effectiveness of minoxidil in treating refractory hypertension in patients with various degrees of renal insufficiency. (In preparation)Google Scholar
  427. 427.
    Usberti, M., Federico, S., Dal Canton, A., Pecoraro, C., Meccariello, S., Stanziale, P. and Andreucci, V. E. (1980). II minoxidil nel controllo rapido e protratto nell’ipertensione grave del bambino. (In preparation)Google Scholar
  428. 428.
    Graham, R. M. and Pettinger, W. A. (1979). Prazosin. N. Engl. J. Med., 300, 232CrossRefPubMedGoogle Scholar
  429. 429.
    Chidsey, C. A. and Gottlieb, T. B. (1974). The pharmacologic basis of antihypertensive therapy: the role of vasodilator drugs. Prog. Cardiovasc. Dis., 17, 99CrossRefPubMedGoogle Scholar
  430. 430.
    Graham, R. M., Thornell, I. R., Gain, J. M., Bagnoli, C., Oates, H. F. and Stokes, G. S. (1976). Prazosin: the first-dose phenomenon. Br. Med. J., 2, 1293CrossRefPubMedGoogle Scholar
  431. 431.
    Curtis, J. A. and Bateman, F. J. A. (1975). Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients. Br. Med. J., 4, 432CrossRefPubMedGoogle Scholar
  432. 432.
    Stokes, G. S. and Oates, H. F. (1978). Prazosin: new alpha-adrenergic blocking agent in treatment of hypertension. Cardiovasc. Med., 3, 41Google Scholar
  433. 433.
    Henning, M. (1978). Mechanism of action of methyldopa: an overview. In Zanchetti, A. (ed.) Methyldopa in Hypertension, pp. 175–179. (Rahway, New Jersey: Merck Sharp and Dohme International)Google Scholar
  434. 434.
    Hansson, L. and Humyor, S. N. (1973). Blood pressure overshoot due to acute Clonidine (Catapres) withdrawal: studies on arterial and urinary catecholamines and suggestions for management of the crisis. Clin. Sci. Mol. Med., 45 (Suppl. 1), 181Google Scholar
  435. 435.
    Jain, A. K., Ryan, J. R. and McMahon, F. G. (1973). The effect of single working doses of methyldopa on blood pressure. Clin. Pharmacol. Ther., 14, 137Google Scholar
  436. 436.
    McLeod, P. J. (1978). Single-dose methyldopa. In Zanchetti, A. (ed.) Methyldopa in Hypertension, pp. 253–257. (Rahway, New Jersey: Merck Sharp and Dohme International)Google Scholar
  437. 437.
    Bricker, N. S. and Fine, L. G. (1978). The trade-off hypothesis: current status. Kidney Int., 13 (Suppl. 8), 5Google Scholar
  438. 438.
    Fiaschi, E., Maschio, G., D’Angelo, A., Bonucci, E., Tessitore, N. and Messa, P. (1978). Low protein diets and bone disease in chronic renal failure. Kidney Int., 13 (Suppl. 8), 79Google Scholar
  439. 439.
    Baker, L. R. I., Akrill, P., Cattell, W. R., Stamp, T. C. B. and Watson, L. (1974). Iatrogenic osteomalacia and myopathy due to phosphate depletion. Br. Med. J., 3, 150CrossRefPubMedGoogle Scholar
  440. 440.
    Dent, C. E. and Winter, C. S. (1974). Osteomalacia due to phosphate depletion from excessive aluminium hydroxide ingestion. Br. Med. J., 1, 551CrossRefPubMedGoogle Scholar
  441. 441.
    Knöchel, J. P. (1977). The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch. Intern. Med., 137, 203CrossRefPubMedGoogle Scholar
  442. 442.
    Clarkson, E. M., Luck, V. A., Hynson, W. V., Bailey, R. R., Eastwood, J. B., Woodhead, J. S., Clements, V. R., Oriordan, J. L. H. and de Wardener, H. E. (1972). The effect of aluminum hydroxide on calcium, phosphorus and aluminum balances, the serum parathyroid hormone concentration and the aluminum content of bone in patients with chronic renal failure. Clin. Sci., 43, 519PubMedGoogle Scholar
  443. 443.
    American Academy of Pediatrics: Report of the Committee on Nutrition, Infantile Scurvy and Nutritional Rickets in the United States. Pediatrics, 29, 646Google Scholar
  444. 444.
    Dent, C. E. and Smith, R. (1969). Nutritional osteomalacia. Q. J. Med., 38, 195PubMedGoogle Scholar
  445. 445.
    Kleeman, C. R., Better, O. S., Massry, S. G. and Maxwell, M. H. (1967). Divalent ion metabolism and osteodystrophy in chronic renal failure. Yale J. Biol. Med., 40, 1PubMedGoogle Scholar
  446. 446.
    Liu, S. G. and Chu, H. I. (1943). Studies of calcium and phosphorus metabolism with special reference to the pathogenesis and effect of dihydrotachysterol (AT 10) and iron. Medicine, 22, 103CrossRefGoogle Scholar
  447. 447.
    Kaye, M. and Sagar, S. (1972). Effect of dihydrotachysterol on calcium absorption in uremia. Metabolism, 21, 815CrossRefPubMedGoogle Scholar
  448. 448.
    Brickman, A. S., Coburn, J. W., Massry, S. G. and Norman, A. W. (1974). 1,25-di-hydroxyvitamin D3 in normal man and patients with renal failure. Ann. Intern. Med., 80, 161PubMedGoogle Scholar
  449. 449.
    Henderson, R. G., Ledingham, J. G. G., Oliver, D., Small, D. G., Russell, R. G. G., Smith, R., Walton, R. J., Preston, C. and Warner, G. T. (1974). Effects of 1,25-di-hydroxycholecalciferol on calcium absorption, muscle weakness and bone disease in chronic renal failure. Lancet, 1, 379CrossRefPubMedGoogle Scholar
  450. 450.
    Coburn, J. W., Brickman, A. S., Sherrard, D. J., Singer, F. R., Wong, E. G. C., Baylink, D. J. and Norman, A. W. (1977). Use of l,25(OH)2-vitamin D3 to separate types of renal osteodystrophy. Proc. Eur. Dial. Transplant. Assoc, 14, 442PubMedGoogle Scholar
  451. 451.
    Chalmers, T. M., Hunter, J. O., Davie, M. W., Szaz, K. F., Pele, B. and Kodicek, E. (1973). 1-Alpha hydroxycholecalciferol as a substitute for the kidney hormone; 1,25-di-hydroxycholecalciferol in chronic renal failure. Lancet, 2, 696CrossRefPubMedGoogle Scholar
  452. 452.
    Peacock, M., Gallagher, J. C. and Nordin, B. E. C. (1974). Action of 1-alpha-hydroxy-vitamin D3 on calcium absorption and bone resorption in man. Lancet, 1, 385CrossRefPubMedGoogle Scholar
  453. 453.
    Pechet, M. M. and Hesses, R. H. (1974). Metabolic and clinical effects of pure crystalline 1-alpha hydroxyvitamin D3 and 1-alpha dihydroxyvitamin D3. Am. J. Med., 57, 13CrossRefGoogle Scholar
  454. 454.
    Fournier, A., Bordier, P., Guéris, J., Sebert, J. L., Marie, P., Ferriere, C., Bedrossian, J. and De Luca, H. F. (1979). Comparison of 1-alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization. Kidney Int., 15, 196CrossRefPubMedGoogle Scholar
  455. 455.
    Teitelbaum, S. L., Bone, J. M., Stein, P. M., Gilden, J. J., Bates, J., Boisseau, V. C. and Avioli, L. V. (1976). The skeletal response of patients with chronic renal insufficiency to 25-hydroxycholecalciferol. J. Am. Med. Assoc., 235, 164CrossRefGoogle Scholar
  456. 456.
    Witmer, G., Margolis, A., Fontaine, O., Fritsch, J., Lenoir, G., Broyer, M. and Balsan, S. (1976). Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure. Kidney Int., 10, 395CrossRefPubMedGoogle Scholar
  457. 457.
    Avioli, L. V. (1973). Collagen metabolism, uremia and bone. Kidney Int., 4, 105CrossRefPubMedGoogle Scholar
  458. 458.
    Miller, E. J. and Matukas, V. J. (1974). Biosynthesis of collagen. Fed. Proc., 33, 1198Google Scholar
  459. 459.
    Jowsey, J. and Riggs, B. L. (1968). Bone changes in a patient with hypervitaminosis. Am. J. Clin. Endocrinol, 28, 1833CrossRefGoogle Scholar
  460. 460.
    Frame, B., Jackson, C. E., Reynolds, W. A. and Umphrey, J. E. (1974). Hypercalcemia and skeletal effects in chronic hypervitaminosis. A. Ann. Intern. Med., 80, 44Google Scholar
  461. 461.
    Havivi, E. and Guggenheim, K. (1975). Effect of hypervitaminosis A on composition of chick cartilage. Int. J. Vitam. Nutr. Res., 45, 307Google Scholar
  462. 462.
    Chertwo, B. S., Williams, G. A., Kiani, R., Stewart, K. L., Hargis, G. K. and Glayter, R. L. (1974). The interactions between vitamin A, vinblastine, and cytochalasin B in parathyroid hormone secretion. Proc. Soc Exp. Biol. Med., 147, 16Google Scholar
  463. 463.
    Kleeman, C. R., Okun, R. and Heller, R. J. (1966). The renal regulation of sodium and potassium in patients with chronic renal failure and the effects of diuretics on the excretion of these ions. Ann. N.Y. Acad. Sci., 139, 520CrossRefPubMedGoogle Scholar
  464. 464.
    Migone, L. and Borghetti, A. (1968). Aspetti fisiopatologici e clinici dell’insufficienza renale. In 69th Congress of Italian Society of Internal Medicine, pp. 1–595. (Roma, Italy: L. Pozzi)Google Scholar
  465. 465.
    Garella, S., Dana, C.L. and Chazan, J. A. (1973). Severity of metabolic acidosis as a determinant of bicarbonate requirements. N. Engl. J. Med., 289, 121CrossRefPubMedGoogle Scholar
  466. 466.
    Arieff, A. I. (1972). Principles of parenteral therapy. A. Principles of parenteral therapy and parenteral nutrition. In Maxwell, M. H. and Kleeman, C. R. (eds.) Clinical Disorders of Fluid and Electrolyte Metabolism. 2nd Edn., pp. 567–589. (New York: McGraw-Hill)Google Scholar
  467. 467.
    Posner, J. B. and Plum, F. (1967). Spinal-fluid pH and neurologic symptoms in systemic acidosis. N. Engl. J. Med., 277, 605CrossRefPubMedGoogle Scholar
  468. 468.
    Finch, C. A. and Lenfant, C. (1972). Oxygen transport in man. N. Engl. J. Med., 286, 407CrossRefPubMedGoogle Scholar
  469. 469.
    Duke, M. and Abelmann, W. H. (1969). The hemodynamic response to chronic anemia. Circulation, 39, 503PubMedGoogle Scholar
  470. 470.
    Neff, M. S., Kim, K. E., Persoff, M., Onesti, G. and Swartz, C. (1971). Hemodynamics of uremic anemia. Circulation, 43, 876PubMedGoogle Scholar
  471. 471.
    Mitchell, T. R. and Pegrum, G. D. (1971). The oxygen affinity of haemoglobin in chronic renal failure. Br. J. Haematol., 21, 463CrossRefPubMedGoogle Scholar
  472. 472.
    Chillar, R. K. and Desforges, J. F. (1974). Red cell organic phosphates in patients with chronic renal failure on maintenance hemodialysis. Br. J. Haematol., 26, 549CrossRefPubMedGoogle Scholar
  473. 473.
    Aljama, P., Ward, M. K., Pierides, A. M., Eastham, E. J., Ellis, H. A., Feest, T. G., Conceicao, S. and Kerr, D. N. S. (1978). Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients. Clin. Nephrol., 10, 101PubMedGoogle Scholar
  474. 474.
    Fisher, J. W., Roh, B. L., Malgor, L. A., Samuels, A. I., Thompson, J., Noveck, R. and Espada, J. (1971). Chemical agents which stimulate erythropoietin production. In Fisher, J. W. (ed.) Kidney Hormones, pp. 343–371. (London: Academic Press)Google Scholar
  475. 475.
    Duckham, J. M. and Lee, H. A. (1976). The treatment of refractory anemia of chronic renal failure with cobalt chloride. Q.J. Med., 178, 277Google Scholar
  476. 476.
    Alexanian, R. (1969). Erythropoietin and erythropoiesis in anemic men following androgens. Blood, 33, 564PubMedGoogle Scholar
  477. 477.
    Mirand, E. A. and Murphy, G. P. (1971). Erythropoietin activity in anephric humans given prolonged androgen treatment. J. Surg. Oncol., 3, 59CrossRefPubMedGoogle Scholar
  478. 478.
    Shaldon, S., Patyna, W. D., Kaltwasser, P., Werner, E., Koch, K. M. and Schoeppe, W. E. (1971). The use of testosterone in bilateral nephrectomized dialysis patients. Trans. Am. Soc. Artif. Intern. Organs, 17, 104PubMedGoogle Scholar
  479. 479.
    Richardson, J. R. Jr. and Weinstein, M. B. (1971). Erythropoietic response of dialyzed patients to testosterone administration. Ann. Intern. Med., 73, 403Google Scholar
  480. 480.
    Choi, E. S. K., Chung, T. J., Morrison, R. S., Myers, C. and Greenberg, M. S. (1974). Hypertriglyceridemia in hemodialysis patients during oral dromostanolone therapy for anemia. Am. J. Clin. Nutr., 27, 901PubMedGoogle Scholar
  481. 481.
    Opelz, G., Mickey, M. R. and Terasaki, P. I. (1972). Identification of unresponsive kidney transplant recipients. Lancet, 1, 868CrossRefPubMedGoogle Scholar
  482. 482.
    Opelz, G. and Terasaki, P. J. (1974). Poor kidney survival in recipients with frozen blood transfusion or no transfusions. Lancet, 2, 696CrossRefPubMedGoogle Scholar
  483. 483.
    Opelz, G. and Terasaki, P. I. (1976). Prolongation effect of blood transfusions on kidney graft survival. Transplantation, 22, 380CrossRefPubMedGoogle Scholar
  484. 484.
    Strom, T. B. and Merrill, J. P. (1977). Hepatitis B, transfusions and renal transplantation. N. Engl. J. Med., 296, 225CrossRefPubMedGoogle Scholar
  485. 485.
    Sirchia, G. (1978). Blood transfusion and kidney transplantation. Dial. Transplant., 7, 390Google Scholar
  486. 486.
    Alexandre, G. P. J. and Van Cangh, P. J. (1978). Influence of blood transfusion on kidney transplantation. Dial. Transplant., 7, 392Google Scholar
  487. 487.
    Brynger, H., Frisk, B., Ahlmen, J., Attman, P. O., Blohme, I., Sandberg, L. and Gelin, L. E. (1977). Graft survival and blood transfusion. Proc. Eur. Dial. Transplant. Assoc, 14, 290PubMedGoogle Scholar
  488. 488.
    Brynger, H., Frisk, B., Ahlmen, J., Blohme, I., Sandberg, L. and Gelin, L. E. (1978). Blood transfusions and graft survival in living related donor transplantation. Dial. Transplant., 7, 396Google Scholar
  489. 489.
    Giordano, C., Esposito, R., Randazzo, G. and Pluvio, M. (1972). Oxystarch as a gastrointestinal sorbent in uremia. In Kluthe, R. (ed.) Uremia, p. 132. (Stuttgart: Georg Thieme Verlag)Google Scholar
  490. 490.
    Giordano, C., Esposito, R. and Pluvio, M. (1973). The effects of oxidized starch on blood and faecal nitrogen in uremia. Proc. Eur. Dial. Transplant. Assoc, 10, 136PubMedGoogle Scholar
  491. 491.
    Giordano, C., Esposito, R., Di Leo, V. A. and Pluvio, M. (1979). Oxycellulose as oral sorbent in uremia. Clin. Nephrol., 11, 142PubMedGoogle Scholar
  492. 492.
    Yatzidis, H. (1978). Preliminary studies with locust bean gum, a new sorbent with great potential. Kidney Int., 13 (Suppl. 8), 152Google Scholar
  493. 493.
    Yatzidis, H., Koutsicos, D. and Digenis, P. (1979). Newer oral sorbents in uremia. Clin. Nephrol., 11, 105PubMedGoogle Scholar
  494. 494.
    Setälä, K. (1978). Bacterial enzymes in uremia management. Kidney Int., 13 (Suppl. 8), S-194Google Scholar
  495. 495.
    Setälä, K. (1979). Treating uremia with soil bacterial enzymes: further developments. Clin. Nephrol., 11, 156PubMedGoogle Scholar
  496. 496.
    Blythe, W. B. (1979). The management of intercurrent medical and surgical problems in the patient with chronic renal failure. In Earley, L. E. and Gottschalk, C. W. (eds.) Strauss and Welt’s Diseases of the Kidney. 3rd Edn., pp. 517–537. (Boston: Little, Brown and Company)Google Scholar
  497. 497.
    Anderson, R. J., Gambertoglio, J. G. and Schrier, R. W. (1976). Clinical Use of Drugs in Renal Failure. (Springfield, Ill.: C. C. Thomas)Google Scholar
  498. 498.
    Cutler, R. E. and Christopher, T. G. (1976). Drug therapy during renal insufficiency and dialytic treatment. In Massry, S. G. and Sellers, A. L. (eds.) Clinical Aspects of Uremia and Dialysis, pp. 427–452. (Springfield, Ill.: C. C. Thomas)Google Scholar
  499. 499.
    Weinstein, L. (1970). Antibiotics. I. The penicillins. In Goodman, L. S. and Gilman, A. (eds.) The Pharmacological Basis of Therapeutics. 4th Edn., pp. 1204–1241. (London: The Macmillan Company)Google Scholar
  500. 500.
    Kampmann, J., Hansen, J. M., Siersbock-Nielsen, K. and Laursen, H. (1972). Effect of some drug on penicillin half-life in blood. Clin. Pharmacol. Ther., 13, 516PubMedGoogle Scholar
  501. 501.
    Schrier, R. W., Bulger, R. J. and Van Arsdel, P. P. (1966). Nephropathy associated with penicillin and homologues. Ann. Intern. Med., 64, 116PubMedGoogle Scholar
  502. 502.
    Baldwin, D. S., Levine, B. B., McCluskey, R. T. and Gallo, G. R. (1968). Renal failure and interstitial nephritis due to penicillin and methicillin. N. Engl. J. Med., 279, 1245CrossRefPubMedGoogle Scholar
  503. 503.
    Love, D. W. and Salter, F. J. (1971). Penicillin and carbenicillin induced neuro-encephalopathy. Drug. Intell. Clin. Pharm., 5, 361Google Scholar
  504. 504.
    Curtis, J. R. and Williams, G. B. (1975). Clinical Management of Chronic Renal Failure. (Oxford: Blackwell Scientific Publications)Google Scholar
  505. 505.
    Bryan, C. S. and Stone, W. J. (1975). Comparably massive penicillin G therapy in renal failure. Ann. Intern. Med., 82, 189PubMedGoogle Scholar
  506. 506.
    Bulger, R. J., Lindholm, D. D., Murray, J. S. and Kirby, W. M. (1964). Effect of uremia on methicillin and oxacillin blood levels. J. Am. Med. Assoc, 187, 319CrossRefGoogle Scholar
  507. 507.
    Kunin, C. M. and Finkelberg, Z. (1970). Oral cephalexin and ampicillin: antimicrobial activity, recovery in urine and persistence in blood of uremic patients. Ann. Intern. Med., 72, 349PubMedGoogle Scholar
  508. 508.
    Jusko, W. J., Lewis, G. P. and Schmitt, G. W. (1973). Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects. Clin. Pharmacol. Ther., 14, 90PubMedGoogle Scholar
  509. 509.
    Tannenberg, A. M., Wicher, K. J. and Rose, N. R. (1971). Ampicillin nephropathy. J. Am. Med. Assoc., 218, 449CrossRefGoogle Scholar
  510. 510.
    Whelton, A., Carter, G. G., Garth, M. A., Darwish, M. A. and Walker, W. G. (1971). Carbenicillin-induced acidosis and seizures. J. Am. Med. Assoc., 218, 1942CrossRefGoogle Scholar
  511. 511.
    Cox, C. E. (1973). Pharmacology of carbenicillin-inadyl sodium in renal insufficiency. J. Infect. Dis., 127 (Suppl.), 157CrossRefGoogle Scholar
  512. 512.
    Bran, J. L., Karl, D. M. and Kaye, D. (1971). Human pharmacology and clinical evaluation of an oral carbenicillin preparation. Clin. Pharmacol. Ther., 12, 525PubMedGoogle Scholar
  513. 513.
    Hinman, A. R. and Wolinsky, E. (1967). Nephrotoxicity associated with the use of cephaloridine. J. Am. Med. Assoc., 200, 724CrossRefGoogle Scholar
  514. 514.
    Kaplan, K., Reisberg, B. and Weinstein, L. (1968). Cephaloridine. Arch. Intern. Med., 121, 17CrossRefPubMedGoogle Scholar
  515. 515.
    Perkins, R. L., Apicella, M. A., Lee, I., Cuppage, F. E. and Saslaw, S. (1968). Cephaloridine and cephalotin: comparative studies of potential nephrotoxicity. J. Lab. Clin. Med., 71, 75PubMedGoogle Scholar
  516. 516.
    Linton, A. L., Bailey, R. R. and Turnbull, D. I. (1972). Relative nephrotoxicity of cephalosporin antibiotics in an animal model. Can. Med. Assoc. J., 107, 414PubMedGoogle Scholar
  517. 517.
    Silverblatt, F., Turck, M. and Bulger, R. (1970). Nephrotoxicity due to cephaloridine: a light and electronmicroscopic study in rabbits. J. Infect. Dis., 122, 33CrossRefPubMedGoogle Scholar
  518. 518.
    Silverblatt, F., Harrison, W. O. and Turck, M. (1973). Nephrotoxicity of cephalosporin antibiotics in experimental animals. J. Infect. Dis., 128 (Suppl.), 367CrossRefGoogle Scholar
  519. 519.
    Dodds, M. G. and Foord, R. D. (1970). Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine. Br. J. Pharmacol., 40, 227PubMedGoogle Scholar
  520. 520.
    Lawson, D. H., Macadam, R. F., Singh, H., Gavras, H. and Linton, A. L. (1970). The nephrotoxicity of cephaloridine. Postgrad. Med. J., 46 (Suppl.), 36Google Scholar
  521. 521.
    Norrby, R., Stengvist, K. and Elgefors, B. (1976). Interaction between cephaloridine and furosemide in man. Scand. J. Infect. Dis., 8, 209PubMedGoogle Scholar
  522. 522.
    Kleinknecht, P., Ganeval, D. and Droz, D. (1973). Acute renal failure after high doses of gentamicin and cephalothin. Lancet, 1, 1129CrossRefPubMedGoogle Scholar
  523. 523.
    Fillastre, J. P., Laumonier, R., Humbert, G., Dubois, D., Metayer, J., Delpech, A., Leroy, J. and Robert, M. (1973). Acute renal failure associated with combined gentamicin and cephalothin therapy. Br. Med. J., 2, 396CrossRefPubMedGoogle Scholar
  524. 524.
    Seldin, D. W., Carter, N. W. and Rector, F. C. Jr. (1971). Consequences of renal failure and their management. In Strauss, M. B. and Welt, L. G. (eds.) Disease of the Kidney. 2nd Edn., pp. 211–272. (Boston: Little, Brown and Company)Google Scholar
  525. 525.
    Levison, M. E., Levison, S. P., Ries, K. and Kaye, D. (1973). Pharmacology of cefazolin in patients with normal and abnormal renal function. J. Infect. Dis., 128 (Suppl.), 354CrossRefGoogle Scholar
  526. 526.
    Onishi, H. R., Zimmerman, S. B. and Stapley, E. O. (1974). Observations on the mode of action of cefoxitin. Ann. N.Y. Acad. Sci., 235, 406CrossRefPubMedGoogle Scholar
  527. 527.
    Geddes, A. M., Schnurr, L. P., Ball, A. P., McGhie, D., Brookes, G. R., Wise, R. and Andrews, J. (1977). Cefoxitin: a hospital study. Br. Med. J., 1, 1126CrossRefPubMedGoogle Scholar
  528. 528.
    Une, T. and Mitsuhashi, S. (1977). Antimicrobial evaluation of cefoxitin, a new semisynthetic cephamycin. Arzneimitt. Forsch., 27, 89PubMedGoogle Scholar
  529. 529.
    Bach, V. T., Roy, J. and Thadepalli, H. (1977). Susceptibility of anaerobic bacteria to cefoxitin and related compounds. Antimicrob. Agents Chemother., 11, 912PubMedGoogle Scholar
  530. 530.
    Thadepalli, H., Webb, D., Roy, I. and Bach, V. (1978). Evaluation of cefoxitin sodium therapy in anaerobic infections. J. Antimicrob. Chem., 4 (Suppl. B), 203Google Scholar
  531. 531.
    Wilson, P., Leung, T. and Williams, J. D. (1978). Antibacterial activity, pharmacokinetics and efficacy of cefoxitin in patients with abdominal sepsis and other infections. J. Antimicrob. Chem., 4 (Suppl. B), 127Google Scholar
  532. 532.
    Trollfors, B., Norrby, R. and Kristianson, K. (1978). Effects on renal function of treatment with cefoxitin sodium alone or in combination with furosemide. J. Antimicrob. Chem., 4 (Suppl. B), 85Google Scholar
  533. 533.
    Baylis, C., Rennke, M. R. and Brenner, B. M. (1977). Mechanisms of the defect in glomerular ultrafiltration associated with gentamicin administration. Kidney Int., 12, 344CrossRefPubMedGoogle Scholar
  534. 534.
    Warner, W. A. and Sanders, E. (1971). Neuromuscular blockade associated with gentamicin therapy. J. Am. Med. Assoc, 215, 1153CrossRefGoogle Scholar
  535. 535.
    Schultze, R. G., Winters, R. E. and Kauffman, H. (1971). Possible nephrotoxicity in gentamicin. J. Infect. Dis., 124 (Suppl.), 145CrossRefGoogle Scholar
  536. 536.
    Wilfert, J. N., Burke, J. P., Bloomer, H. A. and Smith, C. B. (1971). Renal insufficiency associated with gentamicin therapy. J. Infect. Dis., 124 (Suppl.), 148CrossRefGoogle Scholar
  537. 537.
    Cutler, R. E. and Orme, B. M. (1969). Correlation of serum creatinine concentration and kanamycin half-life. J. Am. Med. Assoc, 209, 539CrossRefGoogle Scholar
  538. 538.
    Whelton, A., von Wittenau, M. S., Twomey, T. M., Walker, W. G. and Bianchine, J. R. (1974). Doxycycline pharmacokinetics in the absence of renal function. Kidney Int., 5, 365CrossRefPubMedGoogle Scholar
  539. 539.
    Phillips, M. E., Eastwood, J. B., Curtis, J. R., Gower, P. E. and de Wardener, H. E. (1974). Tetracycline poisoning in renal failure. Br. Med. J., 2, 149CrossRefPubMedGoogle Scholar
  540. 540.
    Singer, I. and Rotenberg, D. (1973). Demeclocycline-induced nephrogenic diabetes insipidus. Ann. Intern. Med., 79, 679PubMedGoogle Scholar
  541. 541.
    Frimpter, G. W., Timpanelli, A. E., Eisenmenger, W. J., Stein, H. S. and Ehrlich, L. I. (1963). Reversible Fanconi syndrome caused by degraded tetracycline. J. Am. Med. Assoc, 184, 11CrossRefGoogle Scholar
  542. 542.
    Kanfer, A., Daniel, F., Vigeral, Ph. and Mery, J. P. (1979). Surdité transitoire chez des insuffisants rénaux traités par l’érithromycine. Nouv. Presse Med., 8, 2283PubMedGoogle Scholar
  543. 543.
    Mery, J. P. and Kanfer, A. (1979). Ototoxicity of erythromycin in patients with renal insufficiency. N. Engl. J. Med., 301, 944PubMedGoogle Scholar
  544. 544.
    Revert, L. (1977). Fosfomycin in patients subjected to periodic hemodialysis. Chemotherapy, 23 (Suppl. 1), 204CrossRefPubMedGoogle Scholar
  545. 545.
    Gobernado, M. and Garcia, J. (1977). Renal insufficiency and fosfomycin. Chemotherapy, 23 (Suppl. 1), 200CrossRefPubMedGoogle Scholar
  546. 546.
    Kalowski, S., Nanra, R. S., Mathew, T. H. and Kincaid-Smith, P. (1973). Deterioration in renal function in association with co-trimoxazole therapy. Lancet, 1, 394CrossRefPubMedGoogle Scholar
  547. 547.
    Mohring, K. and Madsen, P. O. (1971). Treatment of urinary tract infections with oxolinic acid in patients with normal and impaired renal function. Delaware Med. J., 43, 376PubMedGoogle Scholar
  548. 548.
    Grüneberg, R. N. (1974). Oxolinic acid in urinary infections. Lancet, 2, 1088CrossRefPubMedGoogle Scholar
  549. 549.
    Meers, P. D. (1974). Oxolinic acid in urinary infections. Lancet, 2, 721CrossRefPubMedGoogle Scholar
  550. 550.
    Virtanen, S., Kasanen, A., Forsstrom, J., Karmakoski, J. and Kaarsalo, E. (1978). Oxolinic acid in the treatment of the urinary tract infection. Curr. Ther. Res., 23, 376Google Scholar
  551. 551.
    Guyer, B. M. (1974). Drug profile: Prodoxol (oxolinic acid). J. Int. Med. Res., 2, 458Google Scholar
  552. 552.
    Shimizu, M., Nakamura, S., Takase, Y. and Kurobe, N. (1975). Pipemidic acid: absorption, distribution and excretion. Antimicrob. Agents Chemother., 7, 441PubMedGoogle Scholar
  553. 553.
    Humbert, G., Fillastre, J. P. and Leroy, A. (1976). Etude de l’élimination urinaire d’un nouvel antibactérien de synthèse, l’acide pipémidique, chez le sujet normal et l’insuffisant rénal. Sem. Hop. Paris Thérapeutique, 52, 32Google Scholar
  554. 554.
    Calabresi, P. and Parks, R. E. (1970). Alkylating agents, antimetabolites, hormones and other antiproliferative agents. In Goodman, L. S. and Gilman, A. (eds). The Pharmacological Basis of Therapeutics, pp. 1348–1395. (London: The Macmillan Company)Google Scholar

Copyright information

© MTP Press Limited 1982

Authors and Affiliations

  • V. E. Andreucci

There are no affiliations available

Personalised recommendations